<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">41081</article-id><article-id pub-id-type="doi">10.7554/eLife.41081</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Transcriptomic analysis reveals reduced transcriptional activity in the malaria parasite <italic>Plasmodium cynomolgi</italic> during progression into dormancy</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-119227"><name><surname>Bertschi</surname><given-names>Nicole L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-91327"><name><surname>Voorberg-van der Wel</surname><given-names>Annemarie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9403-0515</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-91330"><name><surname>Zeeman</surname><given-names>Anne-Marie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-91326"><name><surname>Schuierer</surname><given-names>Sven</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-91329"><name><surname>Nigsch</surname><given-names>Florian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-56970"><name><surname>Carbone</surname><given-names>Walter</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6150-8295</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-56969"><name><surname>Knehr</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-91328"><name><surname>Gupta</surname><given-names>Devendra K</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-91332"><name><surname>Hofman</surname><given-names>Sam O</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-119262"><name><surname>van der Werff</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-119263"><name><surname>Nieuwenhuis</surname><given-names>Ivonne</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-119264"><name><surname>Klooster</surname><given-names>Els</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-91333"><name><surname>Faber</surname><given-names>Bart W</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-119228"><name><surname>Flannery</surname><given-names>Erika L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0665-7954</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-119229"><name><surname>Mikolajczak</surname><given-names>Sebastian A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-130030"><name><surname>Chuenchob</surname><given-names>Vorada</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" id="author-119265"><name><surname>Shrestha</surname><given-names>Binesh</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" id="author-56971"><name><surname>Beibel</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf12"/></contrib><contrib contrib-type="author" id="author-91337"><name><surname>Bouwmeester</surname><given-names>Tewis</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf13"/></contrib><contrib contrib-type="author" id="author-119866"><name><surname>Kangwanrangsan</surname><given-names>Niwat</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-119867"><name><surname>Sattabongkot</surname><given-names>Jetsumon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3938-4588</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-90412"><name><surname>Diagana</surname><given-names>Thierry T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8520-5683</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf14"/></contrib><contrib contrib-type="author" corresp="yes" id="author-91338"><name><surname>Kocken</surname><given-names>Clemens HM</given-names></name><email>kocken@bprc.nl</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-56972"><name><surname>Roma</surname><given-names>Guglielmo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8020-4219</contrib-id><email>guglielmo.roma@novartis.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con23"/><xref ref-type="fn" rid="conf15"/><xref ref-type="other" rid="dataset1"/><xref ref-type="other" rid="dataset2"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Novartis Institutes for BioMedical Research</institution><institution>Novartis Pharma AG</institution><addr-line><named-content content-type="city">Basel</named-content></addr-line><country>Europe</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Parasitology</institution><institution>Biomedical Primate Research Centre</institution><addr-line><named-content content-type="city">Rijswijk</named-content></addr-line><country>The Netherlands</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Novartis Institute for Tropical Diseases</institution><institution>Novartis Pharma AG</institution><addr-line><named-content content-type="city">Emeryville</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Pathobiology, Faculty of Science</institution><institution>Mahidol University</institution><addr-line><named-content content-type="city">Bangkok</named-content></addr-line><country>Thailand</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Mahidol Vivax Research Unit, Faculty of Tropical Medicine</institution><institution>Mahidol University</institution><addr-line><named-content content-type="city">Bangkok</named-content></addr-line><country>Thailand</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Krzych</surname><given-names>Urszula</given-names></name><role>Reviewing Editor</role><aff><institution>Walter Reed Army Institute of Research</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Akhmanova</surname><given-names>Anna</given-names></name><role>Senior Editor</role><aff><institution>Utrecht University</institution><country>Netherlands</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>27</day><month>12</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e41081</elocation-id><history><date date-type="received" iso-8601-date="2018-08-28"><day>28</day><month>08</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-12-23"><day>23</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Bertschi et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Bertschi et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-41081-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="article-reference" xlink:href="10.7554/eLife.29605"/><abstract><object-id pub-id-type="doi">10.7554/eLife.41081.001</object-id><p>Relapses of <italic>Plasmodium</italic> dormant liver hypnozoites compromise malaria eradication efforts. New radical cure drugs are urgently needed, yet the vast gap in knowledge of hypnozoite biology impedes drug discovery. We previously unraveled the transcriptome of 6 to 7 day-old <italic>P. cynomolgi</italic> liver stages, highlighting pathways associated with hypnozoite dormancy (Voorberg-van der Wel et al., 2017). We now extend these findings by transcriptome profiling of 9 to 10 day-old liver stage parasites, thus revealing for the first time the maturation of the dormant stage over time. Although progression of dormancy leads to a 10-fold decrease in transcription and expression of only 840 genes, including genes associated with housekeeping functions, we show that pathways involved in quiescence, energy metabolism and maintenance of genome integrity remain the prevalent pathways active in mature hypnozoites.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>malaria</kwd><kwd>liver stages</kwd><kwd>hypnozoites</kwd><kwd>transcriptomics</kwd><kwd>plasmodium</kwd><kwd>maturation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Diagana</surname><given-names>Thierry T</given-names></name><name><surname>Kocken</surname><given-names>Clemens HM</given-names></name><name><surname>Roma</surname><given-names>Guglielmo</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Diagana</surname><given-names>Thierry T</given-names></name><name><surname>Kocken</surname><given-names>Clemens HM</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004167</institution-id><institution>Medicines for Malaria Venture</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Diagana</surname><given-names>Thierry T</given-names></name><name><surname>Kocken</surname><given-names>Clemens HM</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Transcriptome profiling of malaria liver-stage parasites provides unprecedented knowledge on genes and pathways expressed in truly dormant hypnozoites and indicates that dormancy is associated with a switch in energy metabolism.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p><italic>Plasmodium vivax</italic> malaria puts 35% of the world’s population at risk of disease (<xref ref-type="bibr" rid="bib49">World Health Organization, 1987</xref>). A large barrier to <italic>P. vivax</italic> eradication is afforded by the parasite’s ability to cause relapsing disease weeks to months or even years after the primary mosquito-mediated infection (<xref ref-type="bibr" rid="bib48">White, 2011</xref>). This aspect of <italic>P. vivax</italic> infection is caused by a dormant liver stage form of the parasite, named the hypnozoite. Hypnozoites can reactivate through unknown mechanisms, continue development into liver schizonts and cause renewed disease. While prophylactic drugs can prevent initial parasite development in the liver (<xref ref-type="bibr" rid="bib54">Zeeman et al., 2016</xref>), there is a need for new radical cure compounds targeting established hypnozoites. There is a vast gap in knowledge surrounding hypnozoite biology that causes a significant setback in developing a novel radical cure drug that can eliminate hypnozoites. Such a drug is urgently needed to aid in malaria eradication because the current radical curative drugs cannot be used in all persons in endemic areas. For instance, primaquine and the recently FDA-approved tafenoquine cannot be administered to patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common genetic disorder in malaria endemic countries, due to serious adverse side-effects and life-threatening drug-induced hemolysis (<xref ref-type="bibr" rid="bib25">Mazier et al., 2009</xref>; <xref ref-type="bibr" rid="bib47">Wells et al., 2010</xref>). For this reason, new and better drugs are urgently needed. One compound that appeared promising in <italic>in vitro</italic> screens, a phosphatidylinositol 4-kinase (PI4K) inhibitor (<xref ref-type="bibr" rid="bib53">Zeeman et al., 2014</xref>), was shown to be active against hypnozoites in a prophylactic, but not radical cure dosing scheme (<xref ref-type="bibr" rid="bib54">Zeeman et al., 2016</xref>). This indicates that ‘early’ hypnozoites differ from ‘established’ hypnozoites and suggests differences in active cellular pathways between the two forms. <italic>P. vivax</italic> hypnozoite biology research is hampered by the absence of an <italic>in vitro</italic> blood stage culture system, which makes the development of <italic>P. vivax</italic> research tools dependent on patient material as a source for sporozoites. The <italic>P. cynomolgi</italic> simian malaria, closely related to <italic>P. vivax,</italic> is a well-validated model for human <italic>P. vivax</italic> malaria useful to study the disease relapse caused by the reactivation of liver hypnozoites. <italic>P. cynomolgi in vitro</italic> liver stage cultures have been established and in combination with the established transfection technology for this parasite this provides unique opportunities for studies into hypnozoite biology. To investigate differences between different aged hypnozoites, we used genetically engineered fluorescent <italic>P. cynomolgi</italic> parasites (<xref ref-type="bibr" rid="bib44">Voorberg-van der Wel et al., 2013</xref>), <italic>in vitro P. cynomolgi</italic> liver stage culture (<xref ref-type="bibr" rid="bib53">Zeeman et al., 2014</xref>), cell-sorting and RNA-seq to expand the recently published liver stage transcriptomes (6 to 7 day-old <italic>in vitro</italic> cultured hypnozoites and replicating liver stages) (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>) by transcriptionally profiling malaria parasite liver stages after 9 to 10 days of <italic>in vitro</italic> culture. The transcriptomic analysis we describe here, together with the previously published study show that hypnozoite maturation is accompanied by a 10-fold decrease in transcriptional activity and the expression of 840 genes of which only ~4% at higher levels (≥10 FPKM). Although established hypnozoites continue to express a subset of genes, a marker gene which specifically distinguishes hypnozoites from schizonts was not detected. Genes and pathways associated with quiescence, energy metabolism and maintenance of genome integrity remain prevalently expressed in mature hypnozoites, indicating that the hypnozoite stage may be defined by a network of regulatory factors cooperating in the maintenance of genome stability and in the epigenetic control of gene expression.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Transcriptome analysis of malaria parasite liver stages after 9 to 10 days of <italic>in vitro</italic> culture</title><p>To gain further understanding of dormancy mechanisms described in hypnozoites at days 6 and 7, we FACS-purified hepatocytes containing GFP-expressing hypnozoites (GFPlow) and liver schizonts (GFPhigh) at later time points, 9 and 10 days after <italic>P. cynomolgi</italic> M strain sporozoite infection. Mean fluorescence intensities, a measure that depends on cell size and fluorescence intensity, slightly increased from day 6 to day 9 in the GFPlow samples, illustrating a small increase in the volume of hypnozoites over time (<xref ref-type="bibr" rid="bib26">Mikolajczak et al., 2015</xref>). A more pronounced increase over time was observed in the GFPhigh samples, indicating significant parasite growth (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Microscopic analysis of quality control samples taken from the FACS-sorted parasites revealed advanced schizogony at day 9 (GFPhigh samples) and small forms that were, similar to day 6 sorted forms, in- or outside hepatocytes (GFPlow samples) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). The GFPlow samples contained substantial amounts of uninfected hepatocytes, possibly due to increased hepatocyte autofluorescence as a result of prolonged culture.</p><p>RNA-sequencing resulted in a dataset containing two independent schizont and hypnozoite samples at day 9, and four independent schizont and hypnozoite samples at day 10 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Gene expression data showed high concordance between biological replicates (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). We observed a strong correlation between schizont (ρ = 0.99 at day 9 and ρ = 0.97 at day 10) and hypnozoite transcriptomes (ρ = 0.85 at day 9 and ρ = 0.87 at day 10), however the hypnozoite samples did not correlate as highly as schizonts between the time points (ρ = 0.82 vs ρ = 0.97). While schizonts revealed a large consensus between genes expressed at days 9 and 10, day 9 and day 10 hypnozoites showed little overlap because a significant number of genes showed low to no transcription levels at day 9 and high expression at day 10 (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>). These included genes involved in merozoite maturation (for example MSP1, AMA1 and SUB1) (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>). In contrast, housekeeping genes (e.g. hsp70) showed similar expression levels at these time points (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>). Given the presence of transcripts of genes involved in schizont maturation and merozoite invasion, we hypothesized and confirmed by RNA fluorescence in situ hybridization (FISH) a contamination of day 10 hypnozoites with schizonts and/or released merozoites. FISH with a probe against <italic>msp1</italic> was positive for schizonts at day 10, while no transcripts were detected in hypnozoites at day 10 (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). In contrast, transcripts for <italic>hsp70</italic> were found both in schizonts and hypnozoites, except in fully mature schizonts (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>).</p><p>These results show that presence of schizont transcripts in the day 10 GFPlow samples requires careful <italic>in vitro</italic> validation for each transcript that is detected in hypnozoites. For this reason, we decided to exclude the day 10 timepoint from further analyses.</p></sec><sec id="s2-2"><title>Late stage liver parasites reveal features of advanced schizogony and dormancy</title><p>We found that later stage (day 9) liver schizonts express a similar number of genes as those observed at days 6/7 (5640 genes at day 9 vs 5702 at day 6/7, with FPKM ≥1). However at day 9 genes are expressed at higher levels (5138 genes at day 9 vs 3582 at day 6/7, with FPKM ≥10) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Most of the genes (94%, 3380 out of total 3582) showing already high expression level at day 6/7 (≥10 FPKM) remain highly expressed at day 9. However, at day 9 we find an additional 1758 genes with increased expression levels (≥10 FPKM) compared to day 6/7. These include genes that are involved in merozoite formation (PALM) or required by merozoites for red blood cell invasion (RhopH3, AMA1, MSP1) and that are already reported to be expressed in late stage liver schizogony (<xref ref-type="bibr" rid="bib37">Sherling et al., 2017</xref>; <xref ref-type="bibr" rid="bib12">Haussig et al., 2011</xref>). Moreover, the sexual stage-specific marker Pvs16, which was previously shown to be expressed in late stage <italic>P. vivax</italic> liver schizonts, also shows upregulation at day 9 compared to day 6/7 (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>) (<xref ref-type="bibr" rid="bib34">Roth et al., 2018</xref>). In addition to invasion pathways, cytoskeleton motor protein pathways showed increased transcriptional activity at day 9 (97%) compared to day 6 (69%) (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). These actin-myosin motor proteins play crucial roles in apicomplexan host cell invasion (<xref ref-type="bibr" rid="bib4">Bargieri et al., 2014</xref>). It is well known in blood stages that these genes exhibit peak expression in late schizont stage only, which correlates with schizont maturation (<xref ref-type="bibr" rid="bib5">Bozdech et al., 2003</xref>). The high transcription level of these motor protein genes in day 9 liver schizonts suggests near to complete schizont maturation at this time point. Overall, the increased transcriptional activity observed in the later stage liver schizonts reveals molecular events associated with progressing schizogony.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.41081.002</object-id><label>Figure 1.</label><caption><title>Comparison of transcriptional activity in schizonts (SZ) and hypnozoites (HZ) at day 6/7 and day 9.</title><p>Left panel: Distribution of average gene expression values in the schizont samples at day 6/7 (light blue; n = 3) and at day 9 (dark blue; n = 2), and distribution of average gene expression values in the hypnozoites samples at day 6/7 (light green; n = 4) and at day 9 (dark green; n = 2). FPKM, Fragments per kilobase of transcript per million mapped reads. Upper right panel: Venn diagrams show the overlap of genes expressed ≥1 FPKM and ≥10 FPKM, respectively, at day 6/7 and at day 9 in the schizont samples. Lower right panel: Venn diagrams show the overlap of genes expressed ≥1 FPKM and ≥10 FPKM, respectively, at day 6/7 and at day 9 in the hypnozoite samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41081.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Quality check of FACS-sorted parasite cells.</title><p>(<bold>A</bold>) Bar chart depicting the median fluorescence intensity (MFI) values of GFPhigh (schizonts) and GFPlow (hypnozoites) samples FACS-sorted at days 6, 9 and 10 post-sporozoite infection. MFI values are depicted as box whisker (min-max) plots. See Materials and methods for details. (<bold>B</bold>) FACS-purified GFPhigh and GFPlow fractions at day nine post sporozoite infection. GFPlow parasites were found both in- and outside hepatocytes after sorting (arrows). Day 9 GFPlow sorted parasite samples contained substantial amounts of uninfected hepatocytes. Scalebar 50 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41081.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Correlation of gene expression values between biological replicates.</title><p>Scatter plot showing all pairwise log10 normalized CPM correlations between samples from (<bold>A</bold>) schizonts and (<bold>B</bold>) hypnozoites. The upper right part of the panel shows the value of the calculated Pearson correlation coefficients.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41081.005</object-id><label>Figure 1—figure supplement 3.</label><caption><title>Possible contamination of day 10 hypnozoites with schizont derived transcripts.</title><p>(<bold>A</bold>) Venn diagrams show the overlap of genes expressed ≥3 FPKM at day 6/7 and 9 in the schizont samples (left, SZ) and in the hypnozoite samples (right, HZ), respectively. (<bold>B</bold>) Upper Table: Known merozoite-specific markers along with their mean expression levels (FPKM) in the schizont and hypnozoite samples at day 9 and day 10. Lower Table: Selected control genes along with their mean expression levels (FPKM) in the schizont and hypnozoite samples at day 9 and day 10. (<bold>C</bold>) RNA-FISH (RNAscope) of a hypnozoite and two liver schizonts at 10 days post-sporozoite infection. Staining of a hypnozoite (HZ) and a schizont (SZ2) probed with hsp70 (cy5). Staining was absent in fully mature schizonts (SZ1). Probing against msp1 (FITC) detected transcripts in schizonts only. Scalebar 10 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41081.006</object-id><label>Figure 1—figure supplement 4.</label><caption><title>Diagram showing mean gene expression values (FPKM) of schizogony markers in the schizont samples at day 6/7 and day 9.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig1-figsupp4-v2.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41081.007</object-id><label>Figure 1—figure supplement 5.</label><caption><title>Expression levels of specific genes of interest.</title><p>(<bold>A</bold>) Table showing hypnozoite-specific genes previously identified in <xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref> passing the cut-off of &gt;2 fold change absolute value and 10% false discovery rate at day 6/7, along with their mean gene expression values (FPKM) in hypnozoites and schizonts at day 9. (<bold>B</bold>) Upper diagram: Mean gene expression values (FPKM) of 3 ApiAP2 factors in the hypnozoite samples at day 6/7 and day 9. Lower diagram: Mean gene expression values (FPKM) of known malaria drug targets (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>) in the hypnozoite samples at day 6/7 and day 9.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig1-figsupp5-v2.tif"/></fig></fig-group><p>In contrast, day 9 hypnozoites showed a lower transcriptional activity compared to day 6/7 with only few genes expressed at higher levels (30 genes at day 9 vs 870 at day 6/7, with FPKM ≥10). This is also reflected in the significant 10-fold decrease of gene expression levels in hypnozoites (e.g. from 5.8 avg FPKM at day 6/7 down to 0.6 avg FPKM at day 9: Wilcoxon test p-value&lt;0.02857). We observed that only 18% of genes expressed in days 6/7 hypnozoites (628 out of 3462 genes with FPKM ≥1) are as well expressed at day 9 (628 out of 840 genes with FPKM ≥1). This transcriptional decrease is even more pronounced for highly expressed genes where only 2.4% of genes expressed at day 6/7 (21 out of 870 genes with FPKM ≥10) show high transcriptional activity also at day 9 (21 out of 30 genes with FPKM ≥10) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The small number of highly expressed genes at day 9 is most likely the result of an overall reduced transcriptional activity ongoing during hypnozoite maturation. Indeed, the nine genes found to be highly expressed only in day 9 hypnozoites mostly encode ribosomal and histone proteins which are also expressed at day 6/7 but just below the cutoff of 10 FPKM. In contrast, over 70% of all genes expressed ≥10 FPKM at day 6/7 are expressed below 1 FPKM at day 9 (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). These results provide for the first time a strong evidence that maturation of the dormant liver stage is associated with continued reduction of its transcriptional activity.</p><p>In the published dataset of day 6/7 a few hypnozoite-specific genes were identified with significantly higher expression levels compared to schizonts and could thus be hypnozoite markers (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). However, all these genes show expression levels &lt;1 FPKM in hypnozoites at day 9, and higher transcriptional levels in schizonts (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5A</xref>). We hence do not find any gene that is exclusively expressed in the hypnozoite population at day 9, concluding that there is no specific marker for dormant stages at the transcriptional level. Notably, the liver-stage-specific AP2-L protein, which is a member of the plant-derived Apicomplexan Apetala2 (ApiAP2) family of transcription factors, showed equivalent transcription levels in hypnozoites at day 6/7 and day 9 (<xref ref-type="bibr" rid="bib3">Balaji et al., 2005</xref>; <xref ref-type="bibr" rid="bib13">Iwanaga et al., 2012</xref>). In contrast, AP2-Q which has been proposed as a master regulator of transcription in hypnozoites (<xref ref-type="bibr" rid="bib6">Cubi et al., 2017</xref>), showed only very low transcription levels in hypnozoites at day 9 (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B</xref>), which corroborates the results of the recently published <italic>P. vivax</italic> hypnozoite transcriptome (<xref ref-type="bibr" rid="bib6">Cubi et al., 2017</xref>; <xref ref-type="bibr" rid="bib11">Gural et al., 2018</xref>). Interestingly, in the <italic>P. vivax</italic> transcriptome, Gural et al. observed another ApiAP2 transcription factor (PV01_0916300) with high transcript abundance in <italic>P. vivax</italic> hypnozoites (<xref ref-type="bibr" rid="bib11">Gural et al., 2018</xref>). Indeed, we also found transcription of this AP2-encoding gene (PcyM_0918000) in <italic>P. cynomolgi</italic> hypnozoites at day 6/7 and day 9 (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B</xref>).</p><p>To evaluate the potential to apply insights from the transcriptome data for drug discovery, we looked at the expression levels of clinically and chemically validated drug targets (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). For almost all drug targets transcription levels had dropped to low levels in day 9 hypnozoites (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B</xref>). Transcription levels of PI4K in hypnozoites at days 6/7 and day 9 are almost zero, which is in line with the proposed early mode of action that explains the lack of radical cure activity of the drug despite its strong prophylactic activity (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B</xref>) (<xref ref-type="bibr" rid="bib54">Zeeman et al., 2016</xref>) and which aligns with the <italic>P. vivax</italic> hypnozoite data of <xref ref-type="bibr" rid="bib11">Gural et al., 2018</xref>. In contrast, day 9 hypnozoites show still a significant number of transcripts for eukaryotic elongation factor 2 (eEF2), albeit at lower levels than at days 6/7, warranting further research into this target for potential radical cure.</p><p>Taken together, our data suggest that while late schizogony at day 9 is associated with increased transcriptional activity compared to days 6/7, continued dormancy at day 9 is associated with a decrease in gene transcription.</p></sec><sec id="s2-3"><title>Dormancy in maturing hypnozoites is associated with a general metabolic shutdown</title><p>We previously reported that schizonts at days 6/7 express over 90% of the malaria pathways annotated in PlasmoDB (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). These included energy and glucose metabolism, such as pentose phosphate cycle enzymes, CoA biosynthesis and mannose/fructose metabolism, as well as some erythrocyte invasion pathways (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). In schizonts at day 9 this percentage is increased to 93% active pathways (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). The only pathways with a decrease in gene activity compared to day 6/7 are involved in remodeling of the host erythrocyte, and expression of genes in the apicoplast. Indeed clustering of the pathways into higher level groups of similar functions (<ext-link ext-link-type="uri" xlink:href="http://mpmp.huji.ac.il/">http://mpmp.huji.ac.il/</ext-link>; April, 2018) revealed that cytoadherence is the only function with expression of less than 70% of the genes (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p><p>In contrast, eight pathways with an increase of over 50% in gene activity at day 9 compared to day 6/7 represent almost exclusively functions involved in parasite invasion, DNA replication and homologous recombination (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Hence, we conclude that our data at day 9 reflects the maturation of merozoites in late schizogony.</p><p>In contrast to schizonts, we previously showed that day 6/7 hypnozoites express less than half of the annotated malaria pathways reflecting the quiescent state and low metabolism that may be expected in dormant forms (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). With only 49 out of 257 (19.1%) pathways expressing more than half of their constituent genes above 1 FPKM, the total number of active pathways is even lower in hypnozoites at day 9 (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.41081.008</object-id><label>Figure 2.</label><caption><title>Pathway analysis of the malaria liver stages.</title><p>(<bold>A</bold>) Heat map representing expression of <italic>Plasmodium</italic> pathways in schizonts and hypnozoites at days 6/7 and 9. A total of 257 biological pathways annotated in <italic>P. falciparum</italic> were assigned to <italic>P. cynomolgi</italic> through orthology (see Materials and methods in <xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). Pathway expression is shown with a color gradient from white (where the fraction of genes detected above 1 FPKM is 0%) to red (where this fraction is 100%). (<bold>B</bold>) Overall percentage of active pathways in schizonts and hypnozoites at days 6/7 and 9.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41081.009</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Expression levels of selected pathways of interest.</title><p>Heat map of pathways clustered into higher-level groups of similar functions (<ext-link ext-link-type="uri" xlink:href="http://mpmp.huji.ac.il/">http://mpmp.huji.ac.il/</ext-link>; April, 2018) in (<bold>A</bold>) Schizonts and (<bold>B</bold>) Hypnozoites at days 6/7 and 9. For each group the mean expression was calculated. Expression is shown with a color gradient from white (where the fraction of genes detected above 1 FPKM is 0%) to red (where this fraction is 100%). (<bold>C</bold>) Selected pathways, which show high expression levels in hypnozoites at days 6/7 and 9.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig2-figsupp1-v2.tif"/></fig></fig-group><p>For further analysis, the 257 pathways were clustered into higher-level groups of similar functions (<ext-link ext-link-type="uri" xlink:href="http://mpmp.huji.ac.il/">http://mpmp.huji.ac.il/</ext-link>; April, 2018) and, for each group, the mean percentage of genes active in the pathways was calculated for hypnozoites at day 6/7 and day 9. This revealed lower transcription levels of genes involved in transcription, translation, replication and merozoite invasion in the day 9 hypnozoites. Functions such as chromatin structure and energy metabolism were less represented in hypnozoites at day 9, however, still showed a moderate expression level (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>).</p><p>A closer look at the energy metabolism in hypnozoites revealed that while glyoxalase, mannose and fructose metabolism are suppressed in hypnozoites at day 9, the pyruvate metabolism, the pentose phosphate cycle and glycolysis are expressed at similar levels as in hypnozoites at day 6/7, suggesting that these pathways represent the main energy source for dormant stages (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Moreover, histone acetylation and methylation as well as chaperone-mediated modulation of nucleosome-histone interactions show from 50% to 100% activation in day 6/7 and day nine hypnozoites, suggesting a possible role of these pathways in the maintenance of liver stage dormancy (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>).</p><p>Further, we show that functional processes such as cytoadherence were already expressed at a very low level in the hypnozoites at day 6/7 and stayed at a very low level at day 9. Interestingly, functions such as protein export (e.g. PTEX), chaperones and protein structure modifications (e.g. HSP70 cycle), mitochondrial respiration and redox metabolism showed either upregulation or sustained expression in day 9 hypnozoites, suggesting a key role in the maintenance of the quiescent state (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Moreover, we show that genes required for fatty acid synthesis, genes coding for enzymes involved in post-translational modifications and genes required for the ATP homeostasis are relatively highly expressed in hypnozoites (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). The latter is of particular interest, since ATP homeostasis was shown to play an essential role in dormancy in other organisms, for example for the non-replicating dormant form of <italic>Mycobacterium tuberculosis</italic> (<xref ref-type="bibr" rid="bib31">Rao et al., 2008</xref>).</p><p>To conclude, our data show that gene expression levels of housekeeping pathways in later stage, day 9 hypnozoites are dampened. Only pathways previously associated with quiescence and required for energy metabolism and maintenance of chromosome integrity remain expressed in hypnozoites.</p></sec><sec id="s2-4"><title>Mature hypnozoites express genes involved in the export and transport of parasite proteins into the host-cell</title><p>Although dormant, the hypnozoite may still interact with its host cell for survival. Two proteins at the parasite-host interface, the <italic>up-regulated in infective sporozoites gene 4</italic> (UIS4) and the <italic>exported protein-1</italic> (EXP-1), located at the site of the parasitophorous vacuole membrane (PVM), have indeed been shown to interact with host cell proteins in rodent malaria models (<xref ref-type="bibr" rid="bib35">Sá E Cunha et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Mueller et al., 2005</xref>; <xref ref-type="bibr" rid="bib29">Petersen et al., 2017</xref>). In <italic>P. vivax,</italic> UIS4 was shown to be present in hypnozoites and schizonts throughout liver stage development, while EXP-1 expression was only observed in mid-stage schizonts (<xref ref-type="bibr" rid="bib26">Mikolajczak et al., 2015</xref>). We found transcripts for those genes in both schizonts and hypnozoites in our day 9 transcriptome data and generated <italic>P. cynomolgi</italic> antibodies against these proteins for validation (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). As expected, IFA with UIS4 antibodies showed signal in both hypnozoites and schizonts at day 9 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). However, we also observed EXP-1 staining in both parasite forms at day 9. Similar to <italic>P. vivax,</italic> EXP-1 staining was close to background at day 2, while UIS4 staining was clearly visible (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). From day 3/4 onwards EXP-1 staining gradually increased over time and appeared to co-localize with the PVM, both in schizonts and hypnozoites. Further investigation of <italic>P. vivax</italic> liver stage parasites from a humanized mouse model confirmed the presence of EXP-1 in hypnozoites (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, procedures were used as described in <xref ref-type="bibr" rid="bib26">Mikolajczak et al. (2015)</xref>), indicating that our findings are not an artifact from cell culture. This shows that, while expression of most genes in the hypnozoite is decreased, other genes may be switched on during its maturation into true dormancy.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.41081.010</object-id><label>Figure 3.</label><caption><title>Validation of genes involved in the export and transport of parasite proteins.</title><p>(<bold>A</bold>) Immunofluorescent staining patterns of UIS4 (Alexa-594), EXP-1 (Alexa-594) and HSP70 (FITC) in day 9 <italic>P. cynomolgi</italic> hypnozoites (HZ) and liver schizonts (SZ). Scalebar 25 μm. (<bold>B</bold>) EXP-1 is expressed in <italic>P. vivax</italic> hypnozoites (HZ) and liver schizonts (SZ) at day 8 post sporozoite infection. Colocalization of EXP-1 and UIS4 suggests that EXP-1 is expressed on the PVM, in agreement with other <italic>Plasmodium</italic> species. DNA was localized with DAPI. Scalebar 5 μm (HZ) and 15 μm (SZ). (<bold>C</bold>) RNA-FISH staining of Alba1 (cy3) and PTEX150 (cy3) in day 10 <italic>P. cynomolgi</italic> hypnozoites (Hz) and liver schizonts (Sz). Scalebar 10 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41081.011</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Validation of selected genes.</title><p>(<bold>A</bold>) Diagram showing mean gene expression values (FPKM) of UIS4 and EXP-1 in hypnozoites at day 6/7 and day 9. (<bold>B</bold>) Immunofluorescent staining patterns of UIS4 (Alexa), EXP-1 (Alexa) and HSP70 (FITC) in <italic>P. cynomolgi</italic> liver stage parasites at different times post sporozoite infection. Scalebar 25 μm. (<bold>C</bold>) Diagram showing mean gene expression values (FPKM) of genes coding for Alba1-4 and genes coding for components of the translocon PTEX in hypnozoites day 6/7 and day 9, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41081-fig3-figsupp1-v2.tif"/></fig></fig-group><p>In the RNA-seq data set of day 9, we found relatively high transcript levels for members of the Alba gene family in hypnozoites, which is in concordance with the previously published data of days 6/7 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>) (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). This gene family plays a crucial role in transcriptional and translational regulation during zygote development as well as in the blood stage of infection (<xref ref-type="bibr" rid="bib32">Reddy et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">Mair et al., 2010</xref>). Indeed we found strong signals for Alba1 transcripts by RNA-FISH at days 6 (not shown) and day 10, both in hypnozoites and schizonts (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), indicating that this gene may also fulfill important regulatory roles in liver stage development, including hypnozoites.</p><p>Further, we showed that protein export is upregulated in hypnozoites at day 9 compared to hypnozoites at day 6/7 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). This includes four out of the five known components of the <italic>Plasmodium</italic> translocon PTEX (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). This complex composed of HSP101, EXP2, TRX2, PTEX150 and PTEX88 plays an essential role for trafficking exported parasite proteins into the erythrocyte cytoplasm or onto the erythrocyte surface during the blood stage of infection in <italic>P. falciparum</italic> (<xref ref-type="bibr" rid="bib8">Elsworth et al., 2014</xref>). Intriguingly, however, it was shown that most known components of the PTEX translocon are expressed in <italic>Plasmodium</italic> liver stages, corroborating our data (<xref ref-type="bibr" rid="bib28">Nyboer et al., 2018</xref>). RNA-FISH revealed that indeed PTEX150 transcripts were found both in day 6 (not shown) and day 10 schizonts and hypnozoites (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). This confirms that PTEX is not unique to the blood stage of infection, but also is present in the liver stage of infection, including hypnozoites. However, PTEX functional role in liver-stages remains to be investigated and might differ from that of blood stage of infection (<xref ref-type="bibr" rid="bib42">Vaughan et al., 2012</xref>; <xref ref-type="bibr" rid="bib16">Kalanon et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">Matz et al., 2015</xref>).</p><p>Taken together, our data show that hypnozoites display lower transcriptional activity with progressing dormancy. With the markedly reduced transcription levels at day 9 post <italic>in vitro</italic> infection compared to day 6/7, we hypothesize that day 9 hypnozoites are the truly dormant parasites which new drugs need to be active against.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>These data add to the previously published transcriptome of day 6/7 parasites (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>) and allows for the first time to study liver-stage schizont and hypnozoite maturation. Our analysis shows that maturation of liver schizonts is associated with a general increase in transcriptional activity. This includes genes previously shown to be essential for merozoite formation and red blood cell invasion (<xref ref-type="bibr" rid="bib34">Roth et al., 2018</xref>; <xref ref-type="bibr" rid="bib41">Swann et al., 2016</xref>). The <italic>in vivo</italic> staining patterns with immune-reagents used to characterize liver stage morphologies (<xref ref-type="bibr" rid="bib34">Roth et al., 2018</xref>) confirmed proper liver stage development.</p><p>Amongst merozoite-specific genes, day 9 schizonts also revealed upregulation of Pvs16, a gametocyte-specific gene. Together with the data of a recent study, showing that a portion of <italic>P. vivax</italic> late-stage schizonts expresses the Pvs16 protein (<xref ref-type="bibr" rid="bib34">Roth et al., 2018</xref>), this result suggests that some merozoites are already committed as gametocytes prior to the erythrocytic cycle.</p><p>In contrast to schizont maturation, we show that progressing dormancy is associated with a metabolic shutdown. Even though transcriptional levels are clearly reduced in day 9 hypnozoites compared to day 6/7 hypnozoites, there are still some specific pathways that show notable expression levels in the mature dormant stage. This includes functions such as energy metabolism, redox metabolism, mitochondrial respiration and chromatin maintenance. Interestingly, these are common features of dormancy found in other microorganisms (<xref ref-type="bibr" rid="bib33">Rittershaus et al., 2013</xref>). Exposed to stress, many microorganisms enter a hardy, non-replicating state, which is able to tolerate adverse environmental conditions, immune responses and prolonged anti-microbial treatments. While cellular adaptations are not exactly the same for all organisms, recent research found some common features of quiescent cells (<xref ref-type="bibr" rid="bib33">Rittershaus et al., 2013</xref>). In the following paragraph, these features are discussed in the light of the acquired data for <italic>Plasmodium</italic> dormant stages.</p><p>Our data propose a switch in energy metabolism, suggesting that pyruvate metabolism, the pentose phosphate cycle and glycolysis remain active in the dormant stage, while glyoxalase, mannose and fructose metabolism are suppressed. In other organisms, the switch to a latent lifestyle was indeed shown to be accompanied by a shift in energy metabolism (<xref ref-type="bibr" rid="bib33">Rittershaus et al., 2013</xref>). Similar to our data, in <italic>Toxoplasma gondii</italic> the formation of latent bradyzoites is accompanied by upregulation of glycolysis (<xref ref-type="bibr" rid="bib14">Jeffers et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Sullivan and Jeffers, 2012</xref>). This is reflected by the prominent expression of pyruvate kinase and lactate dehydrogenase (LDH2) in the latent form as well as confirmed by a knockdown study, showing that LDH2 is essential for bradyzoite formation (<xref ref-type="bibr" rid="bib1">Al-Anouti et al., 2004</xref>). Notably, pyruvate kinase (PcyM_1123400; 3.7 FPKM at day 6/7 (mean) and 1.3 FPKM at day 9 (mean)) and lactate dehydrogenase LDH (PcyM_1234100; 3.7FPKM at day 6/7 (mean) and 3 FPKM at day 9 (mean)) are as well expressed in our transcriptomic dataset of day 6/7 and day 9 hypnozoites, suggesting similar mechanisms.</p><p>Moreover, it was shown that <italic>Mycobacteria tuberculosis</italic> redirects acetyl-CoA from the TCA cycle into fatty acid synthesis to build up carbon storage in the latent stage (<xref ref-type="bibr" rid="bib2">Baek et al., 2011</xref>). We show that genes required for fatty acid synthesis are constantly expressed at high levels in hypnozoites. This suggests that hypnozoites, similar to <italic>M. tuberculosis</italic>, accumulate lipids as carbon storage in preparation for long periods of inactivity.</p><p>Moreover, in <italic>M. tuberculosis</italic>, ATP homeostasis was shown to be critical for survival. In the latent form of <italic>M. tuberculosis</italic>, ATP level is slightly lower compared to proliferating cells, but it is maintained at a steady state. Depletion of ATP or inhibition of the F0F1 ATP synthase involved in ATP synthesis, results in cell death. This shows that de novo ATP synthesis is required to maintain the low ATP level in <italic>M. tuberculosis</italic>, and hence is critical for dormancy (<xref ref-type="bibr" rid="bib31">Rao et al., 2008</xref>). Intriguingly, genes coding for ATP synthase complex are transcribed in day 6/7 hypnozoites and show upregulation in day 9 hypnozoites. It is hence tempting to speculate that similar mechanism as found in the dormant form of <italic>Mycobacteria</italic> are critical for dormancy in <italic>Plasmodium</italic> parasites.</p><p>In addition, in <italic>Toxoplasma</italic> and <italic>Mycobacteria</italic> it was shown that dormant stages are continually exposed to endogenous and exogenous reactive oxygen species (<xref ref-type="bibr" rid="bib33">Rittershaus et al., 2013</xref>; <xref ref-type="bibr" rid="bib17">Kehrer and Klotz, 2015</xref>). It is hence proposed that latent forms must be capable of dealing with long-term exposure to radicals and reactive metabolic byproducts. Indeed, <italic>T. gondii</italic> and <italic>M. tuberculosis</italic> induce a number of enzymes in the latent stage with roles metabolizing oxygen radicals to maintain balanced oxidation-reduction (<xref ref-type="bibr" rid="bib23">Manger et al., 1998</xref>; <xref ref-type="bibr" rid="bib18">Kumar et al., 2011</xref>). Similar to the data of <italic>Toxoplasma</italic> and <italic>Mycobacteria</italic>, we show that redox metabolism is highly active in day 6/7 hypnozoites and stays active with progressing dormancy. Identification of a mechanism which allows the hypnozoite to counter oxidoreductive stress is central for the development of effective intervention strategies, since its perturbation might either kill or awake the parasite.</p><p>Stress response pathways were previously observed to be associated with induction of dormancy. Apart from redox metabolism, we found the heatshock protein 70 (<italic>hsp70</italic>) chaperone cycle to be highly active in late stage hypnozoites. These data were validated by RNA-FISH and immunofluorescence assays. Intriguingly, in <italic>Toxoplasma</italic> expression of <italic>hsp70</italic> is induced during bradyzoite differentiation and its inhibition can suppress bradyzoite development <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib46">Weiss et al., 1998</xref>). Since members of the HSP70 family are associated with stage transition in many different organisms, it is tempting to speculate that, similar to <italic>Toxoplasma,</italic> HSP70 plays a crucial role in the formation and maintenance of the dormant stage. Identification of interaction partners of HSP70 may yield information about the process of stage transition.</p><p>Interestingly, a recent study uncovered a complex ApiAP2 transcriptional network of repressors and activators controlling the switch between replicating tachyzoite and latent bradyzoite formation in <italic>Toxoplasma gondii</italic> (<xref ref-type="bibr" rid="bib19">Lesage et al., 2018</xref>). The ApiAP2 family includes plant-like transcription factors that are key regulators of life cycle transition in <italic>Apicomplexan</italic> parasites. It is speculated that the AP2VIIa-1 is a master regulator which coordinates changes in the <italic>Toxoplasma</italic> transcriptome that leads to bradyzoite conversion (<xref ref-type="bibr" rid="bib30">Radke et al., 2018</xref>). In <italic>Plasmodium spp.</italic> several ApiAP2 transcription factors were identified to play a crucial role in gametocytogenesis (<xref ref-type="bibr" rid="bib15">Kafsack et al., 2014</xref>; <xref ref-type="bibr" rid="bib38">Sinha et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Yuda et al., 2015</xref>), ookinete development (<xref ref-type="bibr" rid="bib50">Yuda et al., 2009</xref>), sporozoite formation (<xref ref-type="bibr" rid="bib51">Yuda et al., 2010</xref>) and liver stage maturation (<xref ref-type="bibr" rid="bib13">Iwanaga et al., 2012</xref>). So far, however, it remains elusive if ApiAP2 factors regulate hypnozoite formation, maturation and/or reactivation. Here, we show that <italic>ap2-l,</italic> an essential factor for liver stage schizont maturation (<xref ref-type="bibr" rid="bib13">Iwanaga et al., 2012</xref>), is not only expressed in schizonts, but also in hypnozoites, suggesting an important role as well in hypnozoite development. In contrast, we could not confirm expression of the proposed quiescence ApiAP2 factor identified by (<xref ref-type="bibr" rid="bib6">Cubi et al., 2017</xref>). Instead, we show that the ApiAP2 transcription factor PcyM_0918000 is transcribed in hypnozoites, corroborating the results of a recent transcriptome study in <italic>P. vivax</italic> (<xref ref-type="bibr" rid="bib11">Gural et al., 2018</xref>). However, this factor is not exclusive for the dormant stage as suggested for a master regulator for hypnozoite conversion. It hence remains to be determined if indeed this ApiAP2 transcription factor and/or an ApiAP2 transcriptional network play a key role in regulating the hypnozoite fate.</p><p>Apart from ApiAP2 transcription factors as master regulators of hypnozoite fate, it is speculated that epigenetic control might be implicated in the maintenance of quiescence of hypnozoites (<xref ref-type="bibr" rid="bib22">Malmquist et al., 2012</xref>). Indeed, exposure of dormant stages to an inhibitor of histone lysine methyltransferases induced an accelerated rate of hypnozoite activation (<xref ref-type="bibr" rid="bib7">Dembélé et al., 2014</xref>). It is hence tempting to speculate that epigenetic processes such as methylation-dependent changes in transcription might control hypnozoite quiescence. Indeed, our data show that pathways of histone acetylation and methylation as well as chaperone-mediated modulation of nucleosome-histone interactions are highly expressed in days 6/7 and day 9 hypnozoites, suggesting a key role in maintaining dormancy.</p><p>To maintain genome fidelity is challenging for quiescent cells, since the low metabolic activity allows for only limited DNA repair mechanisms. One common strategy is to alter chromosomal structure to a more chemically stable form. In <italic>M. tuberculosis</italic> a histone-like protein Lsr2, mediates chromosome compaction and protection from reactive oxygen and nitrogen species (<xref ref-type="bibr" rid="bib40">Summers et al., 2012</xref>). In our transcriptomic dataset, we found that the <italic>P. cynomolgi</italic> homologue of the bacterial histone-like protein (HU) (PcyM_0702400) is expressed in hypnozoites (3.5 FPKM at day 6/7 and 2.2 FPKM at day 9). It is hence tempting to speculate that this protein might play a role in chromosome condensation during dormancy. Moreover, we find Alba genes transcribed in hypnozoites. Members of the Alba family from protozoan parasites bind to both DNA and RNA and are implicated in transcriptional regulation, chromatin packaging, and translational control, as well as cellular differentiation and developmental processes (<xref ref-type="bibr" rid="bib10">Goyal et al., 2016</xref>). In <italic>P. falciparum</italic> for example, Alba proteins were shown not only to drive translational repression in sporozoites, but also to be associated with subtelomeric DNA and epigenetic regulators, suggesting a role in heterochromatin formation (<xref ref-type="bibr" rid="bib43">Vembar et al., 2015</xref>; <xref ref-type="bibr" rid="bib9">Goyal et al., 2012</xref>). Further studies are needed to map epigenetic modifications in hypnozoites, which will hopefully shed light on the complex developmental pathway driving dormancy.</p><p>Finally, we show the translocon PTEX is actively transcribed in hypnozoites. So far, this complex was only described as essential for protein export in blood stage parasites (<xref ref-type="bibr" rid="bib8">Elsworth et al., 2014</xref>). Whether this complex is indeed also important for nutrient acquisition in liver stage parasites, including hypnozoites, remains to be determined.</p><p>To conclude, although we do not identify a specific transcriptional marker for hypnozoites because dormancy is likely associated with a general metabolic shutdown, there are still several specific pathways that show notable expression levels, at least at the transcriptional level, in the mature dormant stage. Interestingly, these pathways were shown to be essential for dormancy in other organisms. Therefore specific targeting of these functions may be a productive strategy to identify novel effective therapies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Ethics statement</title><p>Nonhuman primates were used because no other models (<italic>in vitro</italic> or <italic>in vivo</italic>) were suitable for the aims of this project. The research protocol was approved by the local independent ethical committee conform Dutch law (BPRC Dier Experimenten Commissie, DEC, agreement number #708). Details are described by <xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al. (2017)</xref>.</p></sec><sec id="s4-2"><title>Transgenic <italic>Plasmodium cynomolgi</italic> sporozoite production</title><p><italic>P. cynomolgi</italic> M strain PcyC-PAC-GFP<sub>hsp70</sub>-mCherry<sub>ef1α</sub> (<xref ref-type="bibr" rid="bib44">Voorberg-van der Wel et al., 2013</xref>) sporozoites were produced as described previously (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>).</p></sec><sec id="s4-3"><title>Parasite liver stage culture and cell sorting</title><p>Procedures for liver cell isolation, liver stage culture and cell sorting were essentially as described previously (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). Briefly, transgenic <italic>P. cynomolgi</italic> salivary gland sporozoites were isolated and added to freshly isolated <italic>Macaca mulatta</italic> hepatocytes. Hepatocytes were seeded in 96-well collagen-coated plates at 90,000 hepatocytes per well and 2 days later 50,000 sporozoites were added per well. After 9 or 10 days of culture, infected cells were sorted with a BD FACSAria flowcytometer and fractions were collected in Trizol and stored at −80°C until RNA extraction. Median fluorescence intensity (MFI) values of GFPlow and GFPhigh samples were calculated using four separate recordings of 1 million cells per experiment (day 6, n = 4; days 9 and 10, n = 3).</p></sec><sec id="s4-4"><title>Protein and antibody production</title><p>PcyM_0602100 (UIS4) aa20-166 and PcyM_0924700 (EXP-1) aa19-130 were expressed in <italic>E. coli,</italic> purified using a Ni-IMAC column followed by gel-filtration and used to immunize rats (Eurogentec, Belgium).</p></sec><sec id="s4-5"><title>Immunofluorescence analysis (IFA)</title><p>IFA staining of methanol fixed liver stage parasites was carried out as before (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). Alternatively, parasites were fixed in 4% paraformaldehyde (30 min., room temperature), washed and incubated with primary and secondary antibodies diluted in 1% BSA/0.3% Triton X-100 in PBS.</p></sec><sec id="s4-6"><title>RNAscope in situ hybridization</title><p>For RNA-FISH, <italic>P. cynomolgi</italic> liver stage cultures in 96-well collagen-coated CellCarrier plates (PerkinElmer) were washed once in PBS and fixed in 4% paraformaldehyde (Affymetrix) at room temperature for 30 min. Cultures were then washed, dehydrated and stored in 100% ethanol at −20°C until RNA-FISH was performed using a Tyramide Signal Amplification (TSA) based assay from Advanced Cell Diagnostics (RNAscope Multiplex Fluorescent Assay v2), essentially according to the manufacturer’s instructions. Following rehydration protease digestions were performed using pretreatment solution three from the kit at 1:10 dilution for 20 min. at room temperature. Hybridizations were 2 hr at 40°C. Probes used were directed against <italic>P. cynomolgi</italic> hsp70 (PcyM_0515400, region 606–1837 of XM_004221103.1), PTEX150 (PcyM_1315200 targeting 871–2360 of XM_004224250.1), Alba1 (PcyM_1427300; targeting 101–692 of PcyM_1427300) and MSP1 (PcyM_0731200 targeting 147–1127 of XM_004221774.1). After hybridization, TSA amplification steps were performed as described by the manufacturer. Following DAPI staining, cells were kept in PBS for imaging. Images were acquired with a Leica DMI6000B inverted fluorescence microscope equipped with a DFC365FX camera using a HC PL APO 63x/1.40–0.60 oil objective.</p></sec><sec id="s4-7"><title>RNA sequencing</title><p>Total RNA was isolated using the Direct-zol RNA MiniPrep Kit (Zymo Research) including on-column DNase digestion according to the manufacturer’s instructions. The quality of the RNA samples was assessed with the High Sensitivity RNA kit using the TapeStation 4200 instrument (Agilent Technologies).</p><p>RNA samples were processed using the SMART-Seq v4 Ultra Low Input RNA Kit (Clontech) to generate high-quality cDNA. The results obtained were evaluated with the High Sensitivity DNA kit using the Bioanalyzer 2100 instrument (Agilent Technologies). The cDNA samples were then sheared to 200–500 bp length using a Covaris E220 instrument (Covaris) and subsequently processed with the Low Input Library Prep Kit v2 (Clontech) to generate sequencing libraries. The quality of the libraries was assessed with the D1000 TapeStation kit (Agilent Technologies). RNA-seq cDNA libraries were sequenced in paired-end mode, 2 × 76-base-pair (bp), using the Illumina HiSeq2500 platform. Read quality was assessed by running FastQC (version 0.10) on the FASTQ files. Sequencing reads showed high quality, with a mean Phred score higher than 30 for all base positions. The obtained 76-bp paired-end reads were used for the alignment to the reference genomes and used for the gene expression quantification with the Exon Quantification Pipeline (EQP) (<xref ref-type="bibr" rid="bib36">Schuierer and Roma, 2016</xref>) as described in <xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al. (2017)</xref>.</p><p>To quantify parasite-specific expression for each <italic>P. cynomolgi</italic> gene, we determined the number of sequencing reads aligned to genes and computed gene expression values as the number of Fragments per Kilobase per Million fragments mapped (FPKM). For the normalization of the schizont expression values, we applied the previously developed method of normalization against the total number of host reads (<xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al., 2017</xref>). For the hypnozoite expression values, we used a different normalization scheme since we detected uninfected host cells in the day 9/10 hypnozoite samples via microscopy. These contaminating uninfected host cells led to a higher content of monkey reads in the day 9/10 hypnozoite samples as compared to the day 6/7 hypnozoite samples which were described in <xref ref-type="bibr" rid="bib45">Voorberg-van der Wel et al. (2017)</xref>. So after discarding the samples of day 10 we decided to completely disregard the percentage of monkey reads in the hypnozoite samples and instead use a standard FPKM normalization which only takes the number of parasite reads into account (<xref ref-type="bibr" rid="bib20">Love et al., 2014</xref>). Since we only compare schizont samples with each other and hypnozoite samples with each other, using two different normalization schemes still leads to consistent results. All data are based on FPKM values after such normalization which are provided in supplementary (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to the mosquito breeding facilities in Nijmegen for provision of <italic>Anopheles stephensi</italic> mosquitoes. We thank Francisca van Hassel for preparing graphical representations. We are grateful to the Kappe and Sattabongkot laboratories for continuous support and collaboration in the area of <italic>P. vivax</italic> liver stage research.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf3"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf4"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf5"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf6"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf7"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf8"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf9"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf10"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf11"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf12"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf13"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf14"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn><fn fn-type="COI-statement" id="conf15"><p>Employed by and/or shareholder of Novartis Pharma AG.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Visualization, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Validation, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con9"><p>Validation, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con11"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con12"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con13"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con14"><p>Validation, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con15"><p>Validation, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con16"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con17"><p>Software, Formal analysis, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con18"><p>Resources, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con19"><p>Resources, Validation, Investigation</p></fn><fn fn-type="con" id="con20"><p>Resources, Validation, Investigation</p></fn><fn fn-type="con" id="con21"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Investigation, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con22"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con23"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: Nonhuman primates were used because no other models (in vitro or in vivo) were suitable for the aims of this project. The research protocol was approved by the local independent ethical committee conform Dutch law (BPRC Dier Experimenten Commissie, DEC, agreement number #708). Details are described by (Voorberg-van der Wel et al., 2017).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.41081.012</object-id><label>Supplementary file 1.</label><caption><title><italic>P.cynomolgi</italic> samples used for RNA-seq, <italic>related to</italic> <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-41081-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><object-id pub-id-type="doi">10.7554/eLife.41081.013</object-id><label>Supplementary file 2.</label><caption><title>Genes with expression vaues ≥ 3 FPKM in hypnozoite samples at day 9 or day 10, <italic>related to</italic> <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-41081-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><object-id pub-id-type="doi">10.7554/eLife.41081.014</object-id><label>Supplementary file 3.</label><caption><title>Genes with expression vaues ≥10 FPKM in hypnozoite samples at day 9 and/or day 10, <italic>related to</italic> <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-41081-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="supp4"><object-id pub-id-type="doi">10.7554/eLife.41081.015</object-id><label>Supplementary file 4.</label><caption><title>Expression of <italic>Plasmodium</italic> pathways in schizont and hypnozoite samples at day 9 and day 10.</title><p>The table indicates if pathways are significantly up- or down-regulated over time.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-41081-supp4-v2.xlsx"/></supplementary-material><supplementary-material id="supp5"><object-id pub-id-type="doi">10.7554/eLife.41081.016</object-id><label>Supplementary file 5.</label><caption><title>Gene expression values (FPKM) generated by RNA-seq of hypnozoite (Hz) and liver schizont (Sz) samples, <italic>related to</italic> <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-41081-supp5-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.41081.017</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-41081-transrepform-v2.docx"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The raw RNA-sequencing reads are available in the NCBI Short Read Archive (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra">https://www.ncbi.nlm.nih.gov/sra</ext-link>) under accession number SRP096160.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Guglielmo</surname><given-names>Roma</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Malaria Liver Stages Transcriptome, '18</data-title><source>NCBI Short Read Archive</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRP096160">SRP096160</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Guglielmo</surname><given-names>Roma</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Malaria Liver Stages Transcriptome, '17</data-title><source>NCBI Short Read Archive</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRP096160">SRP096160</pub-id></element-citation></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Anouti</surname> <given-names>F</given-names></name><name><surname>Tomavo</surname> <given-names>S</given-names></name><name><surname>Parmley</surname> <given-names>S</given-names></name><name><surname>Ananvoranich</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The expression of lactate dehydrogenase is important for the cell cycle of Toxoplasma gondii</article-title><source>Journal of Biological Chemistry</source><volume>279</volume><fpage>52300</fpage><lpage>52311</lpage><pub-id pub-id-type="doi">10.1074/jbc.M409175200</pub-id><pub-id pub-id-type="pmid">15459194</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname> <given-names>SH</given-names></name><name><surname>Li</surname> <given-names>AH</given-names></name><name><surname>Sassetti</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Metabolic regulation of mycobacterial growth and antibiotic sensitivity</article-title><source>PLOS Biology</source><volume>9</volume><elocation-id>e1001065</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001065</pub-id><pub-id pub-id-type="pmid">21629732</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaji</surname> <given-names>S</given-names></name><name><surname>Babu</surname> <given-names>MM</given-names></name><name><surname>Iyer</surname> <given-names>LM</given-names></name><name><surname>Aravind</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Discovery of the principal specific transcription factors of Apicomplexa and their implication for the evolution of the AP2-integrase DNA binding domains</article-title><source>Nucleic Acids Research</source><volume>33</volume><fpage>3994</fpage><lpage>4006</lpage><pub-id pub-id-type="doi">10.1093/nar/gki709</pub-id><pub-id pub-id-type="pmid">16040597</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bargieri</surname> <given-names>D</given-names></name><name><surname>Lagal</surname> <given-names>V</given-names></name><name><surname>Andenmatten</surname> <given-names>N</given-names></name><name><surname>Tardieux</surname> <given-names>I</given-names></name><name><surname>Meissner</surname> <given-names>M</given-names></name><name><surname>Ménard</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Host cell invasion by apicomplexan parasites: the junction conundrum</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1004273</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004273</pub-id><pub-id pub-id-type="pmid">25232721</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozdech</surname> <given-names>Z</given-names></name><name><surname>Llinás</surname> <given-names>M</given-names></name><name><surname>Pulliam</surname> <given-names>BL</given-names></name><name><surname>Wong</surname> <given-names>ED</given-names></name><name><surname>Zhu</surname> <given-names>J</given-names></name><name><surname>DeRisi</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum</article-title><source>PLOS Biology</source><volume>1</volume><elocation-id>e5</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0000005</pub-id><pub-id pub-id-type="pmid">12929205</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cubi</surname> <given-names>R</given-names></name><name><surname>Vembar</surname> <given-names>SS</given-names></name><name><surname>Biton</surname> <given-names>A</given-names></name><name><surname>Franetich</surname> <given-names>J-F</given-names></name><name><surname>Bordessoulles</surname> <given-names>M</given-names></name><name><surname>Sossau</surname> <given-names>D</given-names></name><name><surname>Zanghi</surname> <given-names>G</given-names></name><name><surname>Bosson-Vanga</surname> <given-names>H</given-names></name><name><surname>Benard</surname> <given-names>M</given-names></name><name><surname>Moreno</surname> <given-names>A</given-names></name><name><surname>Dereuddre-Bosquet</surname> <given-names>N</given-names></name><name><surname>Le Grand</surname> <given-names>R</given-names></name><name><surname>Scherf</surname> <given-names>A</given-names></name><name><surname>Mazier</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Laser capture microdissection enables transcriptomic analysis of dividing and quiescent liver stages of <italic>Plasmodium</italic> relapsing species</article-title><source>Cellular Microbiology</source><volume>19</volume><elocation-id>e12735</elocation-id><pub-id pub-id-type="doi">10.1111/cmi.12735</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dembélé</surname> <given-names>L</given-names></name><name><surname>Franetich</surname> <given-names>JF</given-names></name><name><surname>Lorthiois</surname> <given-names>A</given-names></name><name><surname>Gego</surname> <given-names>A</given-names></name><name><surname>Zeeman</surname> <given-names>AM</given-names></name><name><surname>Kocken</surname> <given-names>CH</given-names></name><name><surname>Le Grand</surname> <given-names>R</given-names></name><name><surname>Dereuddre-Bosquet</surname> <given-names>N</given-names></name><name><surname>van Gemert</surname> <given-names>GJ</given-names></name><name><surname>Sauerwein</surname> <given-names>R</given-names></name><name><surname>Vaillant</surname> <given-names>JC</given-names></name><name><surname>Hannoun</surname> <given-names>L</given-names></name><name><surname>Fuchter</surname> <given-names>MJ</given-names></name><name><surname>Diagana</surname> <given-names>TT</given-names></name><name><surname>Malmquist</surname> <given-names>NA</given-names></name><name><surname>Scherf</surname> <given-names>A</given-names></name><name><surname>Snounou</surname> <given-names>G</given-names></name><name><surname>Mazier</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures</article-title><source>Nature Medicine</source><volume>20</volume><fpage>307</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1038/nm.3461</pub-id><pub-id pub-id-type="pmid">24509527</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsworth</surname> <given-names>B</given-names></name><name><surname>Matthews</surname> <given-names>K</given-names></name><name><surname>Nie</surname> <given-names>CQ</given-names></name><name><surname>Kalanon</surname> <given-names>M</given-names></name><name><surname>Charnaud</surname> <given-names>SC</given-names></name><name><surname>Sanders</surname> <given-names>PR</given-names></name><name><surname>Chisholm</surname> <given-names>SA</given-names></name><name><surname>Counihan</surname> <given-names>NA</given-names></name><name><surname>Shaw</surname> <given-names>PJ</given-names></name><name><surname>Pino</surname> <given-names>P</given-names></name><name><surname>Chan</surname> <given-names>JA</given-names></name><name><surname>Azevedo</surname> <given-names>MF</given-names></name><name><surname>Rogerson</surname> <given-names>SJ</given-names></name><name><surname>Beeson</surname> <given-names>JG</given-names></name><name><surname>Crabb</surname> <given-names>BS</given-names></name><name><surname>Gilson</surname> <given-names>PR</given-names></name><name><surname>de Koning-Ward</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PTEX is an essential nexus for protein export in malaria parasites</article-title><source>Nature</source><volume>511</volume><fpage>587</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1038/nature13555</pub-id><pub-id pub-id-type="pmid">25043043</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyal</surname> <given-names>M</given-names></name><name><surname>Alam</surname> <given-names>A</given-names></name><name><surname>Iqbal</surname> <given-names>MS</given-names></name><name><surname>Dey</surname> <given-names>S</given-names></name><name><surname>Bindu</surname> <given-names>S</given-names></name><name><surname>Pal</surname> <given-names>C</given-names></name><name><surname>Banerjee</surname> <given-names>A</given-names></name><name><surname>Chakrabarti</surname> <given-names>S</given-names></name><name><surname>Bandyopadhyay</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification and molecular characterization of an Alba-family protein from human malaria parasite Plasmodium falciparum</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>1174</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr821</pub-id><pub-id pub-id-type="pmid">22006844</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyal</surname> <given-names>M</given-names></name><name><surname>Banerjee</surname> <given-names>C</given-names></name><name><surname>Nag</surname> <given-names>S</given-names></name><name><surname>Bandyopadhyay</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Alba protein family: Structure and function</article-title><source>Biochimica Et Biophysica Acta (BBA) - Proteins and Proteomics</source><volume>1864</volume><fpage>570</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1016/j.bbapap.2016.02.015</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gural</surname> <given-names>N</given-names></name><name><surname>Mancio-Silva</surname> <given-names>L</given-names></name><name><surname>Miller</surname> <given-names>AB</given-names></name><name><surname>Galstian</surname> <given-names>A</given-names></name><name><surname>Butty</surname> <given-names>VL</given-names></name><name><surname>Levine</surname> <given-names>SS</given-names></name><name><surname>Patrapuvich</surname> <given-names>R</given-names></name><name><surname>Desai</surname> <given-names>SP</given-names></name><name><surname>Mikolajczak</surname> <given-names>SA</given-names></name><name><surname>Kappe</surname> <given-names>SHI</given-names></name><name><surname>Fleming</surname> <given-names>HE</given-names></name><name><surname>March</surname> <given-names>S</given-names></name><name><surname>Sattabongkot</surname> <given-names>J</given-names></name><name><surname>Bhatia</surname> <given-names>SN</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title><italic>In </italic>vitro culture, drug sensitivity, and transcriptome of plasmodium vivax hypnozoites</article-title><source>Cell Host &amp; Microbe</source><volume>23</volume><fpage>395</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2018.01.002</pub-id><pub-id pub-id-type="pmid">29478773</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haussig</surname> <given-names>JM</given-names></name><name><surname>Matuschewski</surname> <given-names>K</given-names></name><name><surname>Kooij</surname> <given-names>TWA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Inactivation of a Plasmodium apicoplast protein attenuates formation of liver merozoites</article-title><source>Molecular Microbiology</source><volume>81</volume><fpage>1511</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07787.x</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwanaga</surname> <given-names>S</given-names></name><name><surname>Kaneko</surname> <given-names>I</given-names></name><name><surname>Kato</surname> <given-names>T</given-names></name><name><surname>Yuda</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification of an AP2-family protein that is critical for malaria liver stage development</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e47557</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0047557</pub-id><pub-id pub-id-type="pmid">23144823</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffers</surname> <given-names>V</given-names></name><name><surname>Tampaki</surname> <given-names>Z</given-names></name><name><surname>Kim</surname> <given-names>K</given-names></name><name><surname>Sullivan</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A latent ability to persist: differentiation in Toxoplasma gondii</article-title><source>Cellular and Molecular Life Sciences</source><volume>75</volume><fpage>2355</fpage><lpage>2373</lpage><pub-id pub-id-type="doi">10.1007/s00018-018-2808-x</pub-id><pub-id pub-id-type="pmid">29602951</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kafsack</surname> <given-names>BF</given-names></name><name><surname>Rovira-Graells</surname> <given-names>N</given-names></name><name><surname>Clark</surname> <given-names>TG</given-names></name><name><surname>Bancells</surname> <given-names>C</given-names></name><name><surname>Crowley</surname> <given-names>VM</given-names></name><name><surname>Campino</surname> <given-names>SG</given-names></name><name><surname>Williams</surname> <given-names>AE</given-names></name><name><surname>Drought</surname> <given-names>LG</given-names></name><name><surname>Kwiatkowski</surname> <given-names>DP</given-names></name><name><surname>Baker</surname> <given-names>DA</given-names></name><name><surname>Cortés</surname> <given-names>A</given-names></name><name><surname>Llinás</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A transcriptional switch underlies commitment to sexual development in malaria parasites</article-title><source>Nature</source><volume>507</volume><fpage>248</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1038/nature12920</pub-id><pub-id pub-id-type="pmid">24572369</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalanon</surname> <given-names>M</given-names></name><name><surname>Bargieri</surname> <given-names>D</given-names></name><name><surname>Sturm</surname> <given-names>A</given-names></name><name><surname>Matthews</surname> <given-names>K</given-names></name><name><surname>Ghosh</surname> <given-names>S</given-names></name><name><surname>Goodman</surname> <given-names>CD</given-names></name><name><surname>Thiberge</surname> <given-names>S</given-names></name><name><surname>Mollard</surname> <given-names>V</given-names></name><name><surname>McFadden</surname> <given-names>GI</given-names></name><name><surname>Ménard</surname> <given-names>R</given-names></name><name><surname>de Koning-Ward</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Plasmodium translocon of exported proteins component EXP2 is critical for establishing a patent malaria infection in mice</article-title><source>Cellular Microbiology</source><volume>18</volume><fpage>399</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1111/cmi.12520</pub-id><pub-id pub-id-type="pmid">26347246</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehrer</surname> <given-names>JP</given-names></name><name><surname>Klotz</surname> <given-names>LO</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Free radicals and related reactive species as mediators of tissue injury and disease: implications for Health</article-title><source>Critical Reviews in Toxicology</source><volume>45</volume><fpage>765</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.3109/10408444.2015.1074159</pub-id><pub-id pub-id-type="pmid">26610815</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Farhana</surname> <given-names>A</given-names></name><name><surname>Guidry</surname> <given-names>L</given-names></name><name><surname>Saini</surname> <given-names>V</given-names></name><name><surname>Hondalus</surname> <given-names>M</given-names></name><name><surname>Steyn</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Redox homeostasis in mycobacteria: the key to tuberculosis control?</article-title><source>Expert Reviews in Molecular Medicine</source><volume>13</volume><elocation-id>e39</elocation-id><pub-id pub-id-type="doi">10.1017/S1462399411002079</pub-id><pub-id pub-id-type="pmid">22172201</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesage</surname> <given-names>KM</given-names></name><name><surname>Huot</surname> <given-names>L</given-names></name><name><surname>Mouveaux</surname> <given-names>T</given-names></name><name><surname>Courjol</surname> <given-names>F</given-names></name><name><surname>Saliou</surname> <given-names>JM</given-names></name><name><surname>Gissot</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cooperative binding of ApiAP2 transcription factors is crucial for the expression of virulence genes in Toxoplasma gondii</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>6057</fpage><lpage>6068</lpage><pub-id pub-id-type="doi">10.1093/nar/gky373</pub-id><pub-id pub-id-type="pmid">29788176</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mair</surname> <given-names>GR</given-names></name><name><surname>Lasonder</surname> <given-names>E</given-names></name><name><surname>Garver</surname> <given-names>LS</given-names></name><name><surname>Franke-Fayard</surname> <given-names>BM</given-names></name><name><surname>Carret</surname> <given-names>CK</given-names></name><name><surname>Wiegant</surname> <given-names>JC</given-names></name><name><surname>Dirks</surname> <given-names>RW</given-names></name><name><surname>Dimopoulos</surname> <given-names>G</given-names></name><name><surname>Janse</surname> <given-names>CJ</given-names></name><name><surname>Waters</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Universal features of post-transcriptional gene regulation are critical for Plasmodium zygote development</article-title><source>PLOS Pathogens</source><volume>6</volume><elocation-id>e1000767</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000767</pub-id><pub-id pub-id-type="pmid">20169188</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malmquist</surname> <given-names>NA</given-names></name><name><surname>Moss</surname> <given-names>TA</given-names></name><name><surname>Mecheri</surname> <given-names>S</given-names></name><name><surname>Scherf</surname> <given-names>A</given-names></name><name><surname>Fuchter</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum</article-title><source>PNAS</source><volume>109</volume><fpage>16708</fpage><lpage>16713</lpage><pub-id pub-id-type="doi">10.1073/pnas.1205414109</pub-id><pub-id pub-id-type="pmid">23011794</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manger</surname> <given-names>ID</given-names></name><name><surname>Hehl</surname> <given-names>A</given-names></name><name><surname>Parmley</surname> <given-names>S</given-names></name><name><surname>Sibley</surname> <given-names>LD</given-names></name><name><surname>Marra</surname> <given-names>M</given-names></name><name><surname>Hillier</surname> <given-names>L</given-names></name><name><surname>Waterston</surname> <given-names>R</given-names></name><name><surname>Boothroyd</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Expressed sequence tag analysis of the bradyzoite stage of Toxoplasma gondii: identification of developmentally regulated genes</article-title><source>Infection and Immunity</source><volume>66</volume><fpage>1632</fpage><lpage>1637</lpage><pub-id pub-id-type="pmid">9529091</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matz</surname> <given-names>JM</given-names></name><name><surname>Goosmann</surname> <given-names>C</given-names></name><name><surname>Brinkmann</surname> <given-names>V</given-names></name><name><surname>Grützke</surname> <given-names>J</given-names></name><name><surname>Ingmundson</surname> <given-names>A</given-names></name><name><surname>Matuschewski</surname> <given-names>K</given-names></name><name><surname>Kooij</surname> <given-names>TW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Plasmodium berghei translocon of exported proteins reveals spatiotemporal dynamics of tubular extensions</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>12532</elocation-id><pub-id pub-id-type="doi">10.1038/srep12532</pub-id><pub-id pub-id-type="pmid">26219962</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazier</surname> <given-names>D</given-names></name><name><surname>Rénia</surname> <given-names>L</given-names></name><name><surname>Snounou</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A pre-emptive strike against malaria's stealthy hepatic forms</article-title><source>Nature Reviews Drug Discovery</source><volume>8</volume><fpage>854</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1038/nrd2960</pub-id><pub-id pub-id-type="pmid">19876040</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikolajczak</surname> <given-names>SA</given-names></name><name><surname>Vaughan</surname> <given-names>AM</given-names></name><name><surname>Kangwanrangsan</surname> <given-names>N</given-names></name><name><surname>Roobsoong</surname> <given-names>W</given-names></name><name><surname>Fishbaugher</surname> <given-names>M</given-names></name><name><surname>Yimamnuaychok</surname> <given-names>N</given-names></name><name><surname>Rezakhani</surname> <given-names>N</given-names></name><name><surname>Lakshmanan</surname> <given-names>V</given-names></name><name><surname>Singh</surname> <given-names>N</given-names></name><name><surname>Kaushansky</surname> <given-names>A</given-names></name><name><surname>Camargo</surname> <given-names>N</given-names></name><name><surname>Baldwin</surname> <given-names>M</given-names></name><name><surname>Lindner</surname> <given-names>SE</given-names></name><name><surname>Adams</surname> <given-names>JH</given-names></name><name><surname>Sattabongkot</surname> <given-names>J</given-names></name><name><surname>Prachumsri</surname> <given-names>J</given-names></name><name><surname>Kappe</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice</article-title><source>Cell Host &amp; Microbe</source><volume>17</volume><fpage>526</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.02.011</pub-id><pub-id pub-id-type="pmid">25800544</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname> <given-names>AK</given-names></name><name><surname>Camargo</surname> <given-names>N</given-names></name><name><surname>Kaiser</surname> <given-names>K</given-names></name><name><surname>Andorfer</surname> <given-names>C</given-names></name><name><surname>Frevert</surname> <given-names>U</given-names></name><name><surname>Matuschewski</surname> <given-names>K</given-names></name><name><surname>Kappe</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface</article-title><source>PNAS</source><volume>102</volume><fpage>3022</fpage><lpage>3027</lpage><pub-id pub-id-type="doi">10.1073/pnas.0408442102</pub-id><pub-id pub-id-type="pmid">15699336</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyboer</surname> <given-names>B</given-names></name><name><surname>Heiss</surname> <given-names>K</given-names></name><name><surname>Mueller</surname> <given-names>A-K</given-names></name><name><surname>Ingmundson</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Plasmodium liver-stage parasitophorous vacuole: A front-line of communication between parasite and host</article-title><source>International Journal of Medical Microbiology</source><volume>308</volume><fpage>107</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2017.09.008</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname> <given-names>W</given-names></name><name><surname>Stenzel</surname> <given-names>W</given-names></name><name><surname>Silvie</surname> <given-names>O</given-names></name><name><surname>Blanz</surname> <given-names>J</given-names></name><name><surname>Saftig</surname> <given-names>P</given-names></name><name><surname>Matuschewski</surname> <given-names>K</given-names></name><name><surname>Ingmundson</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sequestration of cholesterol within the host late endocytic pathway restricts liver-stage <italic>Plasmodium</italic> development</article-title><source>Molecular Biology of the Cell</source><volume>28</volume><fpage>726</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1091/mbc.e16-07-0531</pub-id><pub-id pub-id-type="pmid">28122820</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radke</surname> <given-names>JB</given-names></name><name><surname>Worth</surname> <given-names>D</given-names></name><name><surname>Hong</surname> <given-names>D</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Sullivan</surname> <given-names>WJ</given-names></name><name><surname>Wilson</surname> <given-names>EH</given-names></name><name><surname>White</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcriptional repression by ApiAP2 factors is central to chronic toxoplasmosis</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1007035</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007035</pub-id><pub-id pub-id-type="pmid">29718996</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname> <given-names>SPS</given-names></name><name><surname>Alonso</surname> <given-names>S</given-names></name><name><surname>Rand</surname> <given-names>L</given-names></name><name><surname>Dick</surname> <given-names>T</given-names></name><name><surname>Pethe</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis</article-title><source>PNAS</source><volume>105</volume><fpage>11945</fpage><lpage>11950</lpage><pub-id pub-id-type="doi">10.1073/pnas.0711697105</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname> <given-names>BP</given-names></name><name><surname>Shrestha</surname> <given-names>S</given-names></name><name><surname>Hart</surname> <given-names>KJ</given-names></name><name><surname>Liang</surname> <given-names>X</given-names></name><name><surname>Kemirembe</surname> <given-names>K</given-names></name><name><surname>Cui</surname> <given-names>L</given-names></name><name><surname>Lindner</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A bioinformatic survey of RNA-binding proteins in Plasmodium</article-title><source>BMC Genomics</source><volume>16</volume><elocation-id>890</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-015-2092-1</pub-id><pub-id pub-id-type="pmid">26525978</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rittershaus</surname> <given-names>ES</given-names></name><name><surname>Baek</surname> <given-names>SH</given-names></name><name><surname>Sassetti</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The normalcy of dormancy: common themes in microbial quiescence</article-title><source>Cell Host &amp; Microbe</source><volume>13</volume><fpage>643</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.05.012</pub-id><pub-id pub-id-type="pmid">23768489</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname> <given-names>A</given-names></name><name><surname>Maher</surname> <given-names>SP</given-names></name><name><surname>Conway</surname> <given-names>AJ</given-names></name><name><surname>Ubalee</surname> <given-names>R</given-names></name><name><surname>Chaumeau</surname> <given-names>V</given-names></name><name><surname>Andolina</surname> <given-names>C</given-names></name><name><surname>Kaba</surname> <given-names>SA</given-names></name><name><surname>Vantaux</surname> <given-names>A</given-names></name><name><surname>Bakowski</surname> <given-names>MA</given-names></name><name><surname>Luque</surname> <given-names>RT</given-names></name><name><surname>Adapa</surname> <given-names>SR</given-names></name><name><surname>Singh</surname> <given-names>N</given-names></name><name><surname>Barnes</surname> <given-names>SJ</given-names></name><name><surname>Cooper</surname> <given-names>CA</given-names></name><name><surname>Rouillier</surname> <given-names>M</given-names></name><name><surname>McNamara</surname> <given-names>CW</given-names></name><name><surname>Mikolajczak</surname> <given-names>SA</given-names></name><name><surname>Sather</surname> <given-names>N</given-names></name><name><surname>Witkowski</surname> <given-names>B</given-names></name><name><surname>Campo</surname> <given-names>B</given-names></name><name><surname>Kappe</surname> <given-names>SHI</given-names></name><name><surname>Lanar</surname> <given-names>DE</given-names></name><name><surname>Nosten</surname> <given-names>F</given-names></name><name><surname>Davidson</surname> <given-names>S</given-names></name><name><surname>Jiang</surname> <given-names>RHY</given-names></name><name><surname>Kyle</surname> <given-names>DE</given-names></name><name><surname>Adams</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1837</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04221-9</pub-id><pub-id pub-id-type="pmid">29743474</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sá E Cunha</surname> <given-names>C</given-names></name><name><surname>Nyboer</surname> <given-names>B</given-names></name><name><surname>Heiss</surname> <given-names>K</given-names></name><name><surname>Sanches-Vaz</surname> <given-names>M</given-names></name><name><surname>Fontinha</surname> <given-names>D</given-names></name><name><surname>Wiedtke</surname> <given-names>E</given-names></name><name><surname>Grimm</surname> <given-names>D</given-names></name><name><surname>Przyborski</surname> <given-names>JM</given-names></name><name><surname>Mota</surname> <given-names>MM</given-names></name><name><surname>Prudêncio</surname> <given-names>M</given-names></name><name><surname>Mueller</surname> <given-names>AK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title><italic>Plasmodium berghei</italic> EXP-1 interacts with host Apolipoprotein H during <italic>Plasmodium</italic> liver-stage development</article-title><source>PNAS</source><volume>114</volume><fpage>E1138</fpage><lpage>E1147</lpage><pub-id pub-id-type="doi">10.1073/pnas.1606419114</pub-id><pub-id pub-id-type="pmid">28137845</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuierer</surname> <given-names>S</given-names></name><name><surname>Roma</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The exon quantification pipeline (EQP): a comprehensive approach to the quantification of gene, exon and junction expression from RNA-seq data</article-title><source>Nucleic Acids Research</source><volume>44</volume><elocation-id>e132</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkw538</pub-id><pub-id pub-id-type="pmid">27302131</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherling</surname> <given-names>ES</given-names></name><name><surname>Knuepfer</surname> <given-names>E</given-names></name><name><surname>Brzostowski</surname> <given-names>JA</given-names></name><name><surname>Miller</surname> <given-names>LH</given-names></name><name><surname>Blackman</surname> <given-names>MJ</given-names></name><name><surname>Ooij</surname> <given-names>Cvan</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The <italic>Plasmodium falciparum</italic> rhoptry protein RhopH3 plays essential roles in host cell invasion and nutrient uptake</article-title><source>eLife</source><volume>6</volume><elocation-id>e23239</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.23239</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname> <given-names>A</given-names></name><name><surname>Hughes</surname> <given-names>KR</given-names></name><name><surname>Modrzynska</surname> <given-names>KK</given-names></name><name><surname>Otto</surname> <given-names>TD</given-names></name><name><surname>Pfander</surname> <given-names>C</given-names></name><name><surname>Dickens</surname> <given-names>NJ</given-names></name><name><surname>Religa</surname> <given-names>AA</given-names></name><name><surname>Bushell</surname> <given-names>E</given-names></name><name><surname>Graham</surname> <given-names>AL</given-names></name><name><surname>Cameron</surname> <given-names>R</given-names></name><name><surname>Kafsack</surname> <given-names>BFC</given-names></name><name><surname>Williams</surname> <given-names>AE</given-names></name><name><surname>Llinás</surname> <given-names>M</given-names></name><name><surname>Berriman</surname> <given-names>M</given-names></name><name><surname>Billker</surname> <given-names>O</given-names></name><name><surname>Waters</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium</article-title><source>Nature</source><volume>507</volume><fpage>253</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1038/nature12970</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>WJ</given-names></name><name><surname>Jeffers</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mechanisms of Toxoplasma gondii persistence and latency</article-title><source>FEMS Microbiology Reviews</source><volume>36</volume><fpage>717</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2011.00305.x</pub-id><pub-id pub-id-type="pmid">22091606</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname> <given-names>EL</given-names></name><name><surname>Meindl</surname> <given-names>K</given-names></name><name><surname>Usón</surname> <given-names>I</given-names></name><name><surname>Mitra</surname> <given-names>AK</given-names></name><name><surname>Radjainia</surname> <given-names>M</given-names></name><name><surname>Colangeli</surname> <given-names>R</given-names></name><name><surname>Alland</surname> <given-names>D</given-names></name><name><surname>Arcus</surname> <given-names>VL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The structure of the oligomerization domain of Lsr2 from Mycobacterium tuberculosis reveals a mechanism for chromosome organization and protection</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e38542</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0038542</pub-id><pub-id pub-id-type="pmid">22719899</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swann</surname> <given-names>J</given-names></name><name><surname>Corey</surname> <given-names>V</given-names></name><name><surname>Scherer</surname> <given-names>CA</given-names></name><name><surname>Kato</surname> <given-names>N</given-names></name><name><surname>Comer</surname> <given-names>E</given-names></name><name><surname>Maetani</surname> <given-names>M</given-names></name><name><surname>Antonova-Koch</surname> <given-names>Y</given-names></name><name><surname>Reimer</surname> <given-names>C</given-names></name><name><surname>Gagaring</surname> <given-names>K</given-names></name><name><surname>Ibanez</surname> <given-names>M</given-names></name><name><surname>Plouffe</surname> <given-names>D</given-names></name><name><surname>Zeeman</surname> <given-names>AM</given-names></name><name><surname>Kocken</surname> <given-names>CH</given-names></name><name><surname>McNamara</surname> <given-names>CW</given-names></name><name><surname>Schreiber</surname> <given-names>SL</given-names></name><name><surname>Campo</surname> <given-names>B</given-names></name><name><surname>Winzeler</surname> <given-names>EA</given-names></name><name><surname>Meister</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>High-throughput luciferase-based assay for the discovery of therapeutics that prevent malaria</article-title><source>ACS Infectious Diseases</source><volume>2</volume><fpage>281</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.5b00143</pub-id><pub-id pub-id-type="pmid">27275010</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughan</surname> <given-names>AM</given-names></name><name><surname>Mikolajczak</surname> <given-names>SA</given-names></name><name><surname>Wilson</surname> <given-names>EM</given-names></name><name><surname>Grompe</surname> <given-names>M</given-names></name><name><surname>Kaushansky</surname> <given-names>A</given-names></name><name><surname>Camargo</surname> <given-names>N</given-names></name><name><surname>Bial</surname> <given-names>J</given-names></name><name><surname>Ploss</surname> <given-names>A</given-names></name><name><surname>Kappe</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Complete Plasmodium falciparum liver-stage development in liver-chimeric mice</article-title><source>Journal of Clinical Investigation</source><volume>122</volume><fpage>3618</fpage><lpage>3628</lpage><pub-id pub-id-type="doi">10.1172/JCI62684</pub-id><pub-id pub-id-type="pmid">22996664</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vembar</surname> <given-names>SS</given-names></name><name><surname>Macpherson</surname> <given-names>CR</given-names></name><name><surname>Sismeiro</surname> <given-names>O</given-names></name><name><surname>Coppée</surname> <given-names>JY</given-names></name><name><surname>Scherf</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The PfAlba1 RNA-binding protein is an important regulator of translational timing in Plasmodium falciparum blood stages</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>212</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0771-5</pub-id><pub-id pub-id-type="pmid">26415947</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voorberg-van der Wel</surname> <given-names>A</given-names></name><name><surname>Zeeman</surname> <given-names>AM</given-names></name><name><surname>van Amsterdam</surname> <given-names>SM</given-names></name><name><surname>van den Berg</surname> <given-names>A</given-names></name><name><surname>Klooster</surname> <given-names>EJ</given-names></name><name><surname>Iwanaga</surname> <given-names>S</given-names></name><name><surname>Janse</surname> <given-names>CJ</given-names></name><name><surname>van Gemert</surname> <given-names>GJ</given-names></name><name><surname>Sauerwein</surname> <given-names>R</given-names></name><name><surname>Beenhakker</surname> <given-names>N</given-names></name><name><surname>Koopman</surname> <given-names>G</given-names></name><name><surname>Thomas</surname> <given-names>AW</given-names></name><name><surname>Kocken</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of Malaria hypnozoite-forms</article-title><source>PLoS ONE</source><volume>8</volume><elocation-id>e54888</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0054888</pub-id><pub-id pub-id-type="pmid">23359816</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voorberg-van der Wel</surname> <given-names>A</given-names></name><name><surname>Roma</surname> <given-names>G</given-names></name><name><surname>Gupta</surname> <given-names>DK</given-names></name><name><surname>Schuierer</surname> <given-names>S</given-names></name><name><surname>Nigsch</surname> <given-names>F</given-names></name><name><surname>Carbone</surname> <given-names>W</given-names></name><name><surname>Zeeman</surname> <given-names>AM</given-names></name><name><surname>Lee</surname> <given-names>BH</given-names></name><name><surname>Hofman</surname> <given-names>SO</given-names></name><name><surname>Faber</surname> <given-names>BW</given-names></name><name><surname>Knehr</surname> <given-names>J</given-names></name><name><surname>Pasini</surname> <given-names>E</given-names></name><name><surname>Kinzel</surname> <given-names>B</given-names></name><name><surname>Bifani</surname> <given-names>P</given-names></name><name><surname>Bonamy</surname> <given-names>GMC</given-names></name><name><surname>Bouwmeester</surname> <given-names>T</given-names></name><name><surname>Kocken</surname> <given-names>CHM</given-names></name><name><surname>Diagana</surname> <given-names>TT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A comparative transcriptomic analysis of replicating and dormant liver stages of the relapsing malaria parasite <italic>Plasmodium cynomolgi</italic></article-title><source>eLife</source><volume>6</volume><elocation-id>e29605</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.29605</pub-id><pub-id pub-id-type="pmid">29215331</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname> <given-names>LM</given-names></name><name><surname>Ma</surname> <given-names>YF</given-names></name><name><surname>Takvorian</surname> <given-names>PM</given-names></name><name><surname>Tanowitz</surname> <given-names>HB</given-names></name><name><surname>Wittner</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Bradyzoite development in Toxoplasma gondii and the hsp70 stress response</article-title><source>Infection and Immunity</source><volume>66</volume><fpage>3295</fpage><lpage>3302</lpage><pub-id pub-id-type="pmid">9632598</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname> <given-names>TN</given-names></name><name><surname>Burrows</surname> <given-names>JN</given-names></name><name><surname>Baird</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination</article-title><source>Trends in Parasitology</source><volume>26</volume><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2009.12.005</pub-id><pub-id pub-id-type="pmid">20133198</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Determinants of relapse periodicity in Plasmodium vivax malaria</article-title><source>Malaria Journal</source><volume>10</volume><elocation-id>297</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-10-297</pub-id><pub-id pub-id-type="pmid">21989376</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="report"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><year iso-8601-date="1987">1987</year><source>World Malaria Report 2015</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><ext-link ext-link-type="uri" xlink:href="http://www.who.int/malaria/publications/world-malaria-report-2015/en/">http://www.who.int/malaria/publications/world-malaria-report-2015/en/</ext-link></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuda</surname> <given-names>M</given-names></name><name><surname>Iwanaga</surname> <given-names>S</given-names></name><name><surname>Shigenobu</surname> <given-names>S</given-names></name><name><surname>Mair</surname> <given-names>GR</given-names></name><name><surname>Janse</surname> <given-names>CJ</given-names></name><name><surname>Waters</surname> <given-names>AP</given-names></name><name><surname>Kato</surname> <given-names>T</given-names></name><name><surname>Kaneko</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Identification of a transcription factor in the mosquito-invasive stage of malaria parasites</article-title><source>Molecular Microbiology</source><volume>71</volume><fpage>1402</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06609.x</pub-id><pub-id pub-id-type="pmid">19220746</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuda</surname> <given-names>M</given-names></name><name><surname>Iwanaga</surname> <given-names>S</given-names></name><name><surname>Shigenobu</surname> <given-names>S</given-names></name><name><surname>Kato</surname> <given-names>T</given-names></name><name><surname>Kaneko</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Transcription factor AP2-Sp and its target genes in malarial sporozoites</article-title><source>Molecular Microbiology</source><volume>75</volume><fpage>854</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.07005.x</pub-id><pub-id pub-id-type="pmid">20025671</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuda</surname> <given-names>M</given-names></name><name><surname>Iwanaga</surname> <given-names>S</given-names></name><name><surname>Kaneko</surname> <given-names>I</given-names></name><name><surname>Kato</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Global transcriptional repression: An initial and essential step for Plasmodium sexual development</article-title><source>PNAS</source><volume>112</volume><fpage>12824</fpage><lpage>12829</lpage><pub-id pub-id-type="doi">10.1073/pnas.1504389112</pub-id><pub-id pub-id-type="pmid">26417110</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeeman</surname> <given-names>A-M</given-names></name><name><surname>van Amsterdam</surname> <given-names>SM</given-names></name><name><surname>McNamara</surname> <given-names>CW</given-names></name><name><surname>Voorberg-van der Wel</surname> <given-names>A</given-names></name><name><surname>Klooster</surname> <given-names>EJ</given-names></name><name><surname>van den Berg</surname> <given-names>A</given-names></name><name><surname>Remarque</surname> <given-names>EJ</given-names></name><name><surname>Plouffe</surname> <given-names>DM</given-names></name><name><surname>van Gemert</surname> <given-names>G-J</given-names></name><name><surname>Luty</surname> <given-names>A</given-names></name><name><surname>Sauerwein</surname> <given-names>R</given-names></name><name><surname>Gagaring</surname> <given-names>K</given-names></name><name><surname>Borboa</surname> <given-names>R</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Kuhen</surname> <given-names>K</given-names></name><name><surname>Glynne</surname> <given-names>RJ</given-names></name><name><surname>Chatterjee</surname> <given-names>AK</given-names></name><name><surname>Nagle</surname> <given-names>A</given-names></name><name><surname>Roland</surname> <given-names>J</given-names></name><name><surname>Winzeler</surname> <given-names>EA</given-names></name><name><surname>Leroy</surname> <given-names>D</given-names></name><name><surname>Campo</surname> <given-names>B</given-names></name><name><surname>Diagana</surname> <given-names>TT</given-names></name><name><surname>Yeung</surname> <given-names>BKS</given-names></name><name><surname>Thomas</surname> <given-names>AW</given-names></name><name><surname>Kocken</surname> <given-names>CHM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>KAI407, a potent non-8-aminoquinoline compound that kills plasmodium cynomolgi early dormant liver stage parasites <italic>in vitro</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>58</volume><fpage>1586</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1128/AAC.01927-13</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeeman</surname> <given-names>A-M</given-names></name><name><surname>Lakshminarayana</surname> <given-names>SB</given-names></name><name><surname>van der Werff</surname> <given-names>N</given-names></name><name><surname>Klooster</surname> <given-names>EJ</given-names></name><name><surname>Voorberg-van der Wel</surname> <given-names>A</given-names></name><name><surname>Kondreddi</surname> <given-names>RR</given-names></name><name><surname>Bodenreider</surname> <given-names>C</given-names></name><name><surname>Simon</surname> <given-names>O</given-names></name><name><surname>Sauerwein</surname> <given-names>R</given-names></name><name><surname>Yeung</surname> <given-names>BKS</given-names></name><name><surname>Diagana</surname> <given-names>TT</given-names></name><name><surname>Kocken</surname> <given-names>CHM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>PI4 kinase is a prophylactic but not radical curative target in plasmodium vivax-type malaria parasites</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>60</volume><fpage>2858</fpage><lpage>2863</lpage><pub-id pub-id-type="doi">10.1128/AAC.03080-15</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.41081.024</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Krzych</surname><given-names>Urszula</given-names></name><role>Reviewing Editor</role><aff><institution>Walter Reed Army Institute of Research</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>[Editors’ note: the authors were asked to provide a plan for revisions before the editors issued a final decision. What follows is the editors’ letter requesting such plan.]</p><p>Thank you for sending your article entitled &quot;Transcriptomic analysis reveals malaria hypnozoite maturation&quot; for peer review at <italic>eLife</italic>. Your article is being reviewed by Anna Akhmanova as the Senior Editor Editor, a Reviewing Editor, and three reviewers.</p><p>Given the list of essential revisions, including new experiments, the editors and reviewers invite you to respond within the next two weeks with an action plan and timetable for the completion of the additional work. We plan to share your responses with the reviewers and then issue a binding recommendation.</p><p>As you can see from the comments included below, each reviewer expressed positive views regarding the organization and the performance of the experiments as well as the robustness of your results on transcriptomics during the development of <italic>P. cynomolgi</italic>. While they considered the information to be of value and worthy of publication, they also commented on the small incremental step that your data provide and thus questioned the advancement towards understanding dormancy of hypnozoites. To substantially enhance your story, they suggested performing additional experiments: (1) to demonstrate protein expression of the genes transcribed during previously reported biomarkers for day 6/7 hypnozoites that were not found at day 9; (2) to validate some pathways revealed at the transcriptomic level.</p><p><italic>Reviewer #1:</italic> </p><p>The paper by Bertschi et al. describes the transcriptomes of <italic>P. cynomolgi</italic> liver stage hypnozoites and liver stage schizonts at day 9 and day 10 post infection. The parasite material was derived from <italic>in vitro</italic>-cultured hepatocyte infections that were subject to cell sorting for enrichment of parasite-infected hepatocytes. The work is an extension of data recently published by the same group in <italic>eLife</italic> (Voorberg-van der Wel et al., 2017), which described hypnozoite and schizont transcriptomes from parasites at days 6/7 post infection.</p><p>The experimental work is technically sound, and the data analysis is reasonably well done. The main conclusion drawn by the authors is that more 'mature' day 9 hypnozoites exhibit similar gene expression patterns when compared to day 6/7 hypnozoites but the former shows a further decrease of transcription.</p><p>While the work is of value and a descriptive and incremental step forward towards the delineation of liver stage gene expression profiles and gene expression in hypnozoites, I cannot see that it provides a significant step towards an understanding of the molecular mechanisms of dormancy and persistence of hypnozoites. It is entirely possible that the answer to the question &quot;what regulates dormancy&quot; will not be revealed by further transcriptome analysis beyond what has been recently published (Voorberg-van der Wel et al., 2017; Gural et al., 2018) and this manuscript further confirms this problem. It might be time that the focus is shifted towards potential posttranscriptional or posttranslational mechanisms that might regulate dormancy.</p><p><italic>Reviewer #2:</italic> </p><p>Bertschi and colleagues unravel the transcriptome of 9 to 10-day-old <italic>P. cynomolgi</italic> liver stage parasites, including the maturation of its dormant stage hypnozoite in their manuscript, titled: &quot;Transcriptomic analysis reveals malaria hypnozoite maturation.&quot; Data analysis shows that the progression of parasite dormancy leads to a 10-fold decrease in transcription with only 840 transcribed genes. Expression analysis shows that pathways involved in quiescence, energy metabolism and maintenance of genome integrity remain the prevalent pathways active in mature hypnozoites. The manuscript is well written. The data generated are robust, well validated and further confirm the importance of epigenetic control in parasite development. I would, however, like to stress that while the described work has been thoroughly performed, the work appears narrow and incremental to previous published datasets. Additional experiments targeting/validating the identified pathways as essential for hypnozoite persistence would hold more value. Is there anyway the team can test the inhibitory activity of drugs/molecules targeting histone-modifying enzymes such as histone acetyltransferases (HATs), histone methyltransferases (HMT) or histone chaperones against hypnozoite maturation and survival? This would significantly improve the relevance of this manuscript.</p><p><italic>Reviewer #3:</italic> </p><p>Although the sample size is small, this manuscript shows convincingly that as hypnozoites mature from day 6/7 to day 9, transcriptional activity is massively reduced. This is in stark contrast to the increased transcriptional activity at the same timepoints during schizont development. There is a strong rationale for doing this work because in order for therapeutics to provide effective radical cure, they must target processes in even the most dormant of hypnozoites. Although the inferences of this study are limited to <italic>in vitro</italic> experiments using non-human malaria, the authors point out several consistencies of these results with <italic>P. vivax</italic> studies and these results also corroborate the prophylactic but not radical curative activity of PI4K. The manuscript is well organized, and the conclusions are supported by the design and analysis of their experiments. I would recommend with work for publication.</p><p>[Editors’ note: formal revisions were requested, following approval of the authors’ plan of action.]</p><p>Thank you for choosing to send your work entitled &quot;Transcriptomic analysis reveals malaria hypnozoite maturation&quot; for consideration at <italic>eLife</italic>. Your plan has been considered by a Senior Editor, Reviewing Editor and three reviewers, and we are prepared to consider a revised submission.</p><p>We will not request any additional experiments, but we will suggest that the authors do respond to the other comments posted by the reviewers – these are mainly editorial in nature – and to revise the title of the manuscript.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.41081.025</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>[Editors’ note: what follows is the authors’ plan to address the revisions.]</p><disp-quote content-type="editor-comment"><p>As you can see from the comments included below, each reviewer expressed positive views regarding the organization and the performance of the experiments as well as the robustness of your results on transcriptomics during the development of P. cynomolgi. While they considered the information to be of value and worthy of publication, they also commented on the small incremental step that your data provide and thus questioned the advancement towards understanding dormancy of hypnozoites. To substantially enhance your story, they suggested performing additional experiments: (1) to demonstrate protein expression of the genes transcribed during previously reported biomarkers for day 6/7 hypnozoites that were not found at day 9;</p></disp-quote><p>This is an interesting suggestion; however, the analysis of the day 6/7 transcriptome data unfortunately did not detect any hypnozoite-specific biomarkers. This means that we do not have any hypnozoite biomarkers we could select for the proposed experiment at day 9.</p><p>In the previous manuscript, we indicated a dozen of transcripts upregulated in the hypnozoites versus schizonts, which correspond to genes with low expression levels in the hypnozoites and very-low expression levels in the schizonts.Thefollow-up validation of the most upregulated gene in hypnozoites, a member of the ETRAMP family, could not confirm protein expression in sporozoites, hypnozoites or schizonts during liver stage development; this appeared to be due to a different alternative splicing (intron retention events) occurring in these stages, resulting in the presence of premature stop codons in the mRNA sequence and hence in the absence of protein expression at days 6 and 7.Thus, the ETRAMP protein would not qualify as a hypnozoite-specific marker to be validated at day 9.</p><p>Selecting the other low-level transcribed genes from the day 6/7 hypnozoite transcriptome, raising antibodies to recombinant proteins (in our hands, antibodies against synthetic peptides are rarely reactive with malaria proteins), preparing new EEF cultures and probing those with the antibodies could easily take 6 months and would require another monkey infection.</p><p>In addition, we understand that the reviewer raised this point merely as an interesting route to follow, beyond the scope of our current work, and they do not seem to suggest additional experiments.</p><disp-quote content-type="editor-comment"><p>(2) to validate some pathways revealed at the transcriptomic level.</p></disp-quote><p>Reviewer 2 suggests evaluating the effect of compounds targeting histone-modifying enzymes. This is also an interesting suggestion but would require a massive number of studies that we feel are beyond the scope of this paper. In fact, we would expect the effects of these compounds to be pleiotropic by definition and to lead to the generation of data that may be very difficult to interpret and would require substantial validation even if we see an effect. To more effectively test this type of compounds we would have to develop new types of assays where we can follow individual parasites over time. A pilot experiment with a limited set of inhibitors may likely take at least 6 months, without any guaranteed success. For this reason, we would prefer to consider the drug screening as a new chapter compared to the proposed “research advance” article that builds on and complements our recent paper of malaria liver stage transcriptomics.</p><p>[Editors’ notes: the authors’ response after being formally invited to submit a revised submission follows.]</p><disp-quote content-type="editor-comment"><p>We will not request any additional experiments, but we will suggest that the authors do respond to the other comments posted by the reviewers – these are mainly editorial in nature – and to revise the title of the manuscript.</p></disp-quote><p>We carefully addressed the concerns of the referees and give detailed answers to the different points below. In addition, we revised the title of our manuscript as follows:</p><p>“Transcriptomic analysis reveals reduced transcriptional activity in malaria hypnozoites during progression into dormancy”.</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>The paper by Bertschi et al. describes the transcriptomes of P. cynomolgi liver stage hypnozoites and liver stage schizonts at day 9 and day 10 post infection. The parasite material was derived from <italic>in vitro</italic>-cultured hepatocyte infections that were subject to cell sorting for enrichment of parasite-infected hepatocytes. The work is an extension of data recently published by the same group in eLife (Voorberg-van der Wel et al., 2017), which described hypnozoite and schizont transcriptomes from parasites at days 6/7 post infection.</p><p>The experimental work is technically sound, and the data analysis is reasonably well done. The main conclusion drawn by the authors is that more 'mature' day 9 hypnozoites exhibit similar gene expression patterns when compared to day 6/7 hypnozoites but the former shows a further decrease of transcription.</p><p>While the work is of value and a descriptive and incremental step forward towards the delineation of liver stage gene expression profiles and gene expression in hypnozoites, I cannot see that it provides a significant step towards an understanding of the molecular mechanisms of dormancy and persistence of hypnozoites. It is entirely possible that the answer to the question &quot;what regulates dormancy&quot; will not be revealed by further transcriptome analysis beyond what has been recently published (Voorberg-van der Wel et al., 2017; Gural et al., 2018) and this manuscript further confirms this problem. It might be time that the focus is shifted towards potential posttranscriptional or posttranslational mechanisms that might regulate dormancy.</p></disp-quote><p>We thank the reviewer for this thorough review and agree with the need to shift the focus of future studies towards posttranscriptional or posttranslational mechanisms that might regulate dormancy in the hypnozoite.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>Bertschi and colleagues unravel the transcriptome of 9 to 10-day-old P. cynomolgi liver stage parasites, including the maturation of its dormant stage hypnozoite in their manuscript, titled: &quot;Transcriptomic analysis reveals malaria hypnozoite maturation.&quot; Data analysis shows that the progression of parasite dormancy leads to a 10-fold decrease in transcription with only 840 transcribed genes. Expression analysis shows that pathways involved in quiescence, energy metabolism and maintenance of genome integrity remain the prevalent pathways active in mature hypnozoites. The manuscript is well written. The data generated are robust, well validated and further confirm the importance of epigenetic control in parasite development. I would, however, like to stress that while the described work has been thoroughly performed, the work appears narrow and incremental to previous published data sets. Additional experiments targeting/validating the identified pathways as essential for hypnozoite persistence would hold more value. Is there anyway the team can test the inhibitory activity of drugs/molecules targeting histone-modifying enzymes such as histone acetyltransferases (HATs), histone methyltransferases (HMT) or histone chaperones against hypnozoite maturation and survival? This would significantly improve the relevance of this manuscript.</p></disp-quote><p>We thank the reviewer for this thorough review and for the suggestion to perform additional drug screening with drugs targeting histone-modifying enzymes. In our revision plan, we have clearly addressed the main challenges related to the execution of these follow up experiments.</p></body></sub-article></article>